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ABSTRACT
ENZYME, COSOLVENT AND SUBSTRATE INTERACTIONS IN PLE
HYDROLYSIS REACTIONS AND EVALUATION OF THE STABILITY
OF AN UNNATURAL GLUTATHIONE ANALOGUE
by Maureen Elizabeth Smith
December 2014
Prochiral diester malonates have been hydrolyzed in the presence of Pig Liver
Esterase (PLE). Several of the diesters produced the respective half-ester in moderate to
high enantioselectivity. A series of cosolvent assays were performed to evaluate the
ability of the cosolvent to influence the enantioselective outcome of the hydrolysis
reactions. Ethanol produced the largest changes in enantioselectivity of all solvents
evaluated. The isoenzymes of PLE were also evaluated and provided very different
enantioselective outcomes than that of crude PLE. A series of NMR titrations was
performed to explore the interactions between the substrates and ethanol cosolvents.
Improvements to our previously reported mass spectrometry assay for the
determination of the enantioselectivity of the PLE hydrolysis reaction are discussed. The
improvements to this assay will allow for the determination of both yield and
enantioselectivity of the PLE hydrolysis reaction in a single analysis.
A glutathione analogue containing α-methyl cysteine has been evaluated for
inhibitory activity against the enzyme glutathione reductase (GR). The methylated
glutathione analogue (mGSSG) has been found to be an inhibitor of the GR enzyme.
Molecular modeling studies suggest that the disulfide bond in the mGSSG is twisted in
comparison to the natural GSSG.
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1
CHAPTER I
INTRODUCTION
Within the past few years, a variety of methods have been developed for the
synthesis of unnatural amino acids.1-7 These unnatural amino acids can be incorporated
into small peptides drugs and evaluated for their stability against proteases.8,9 One of the
most interesting strategies makes use of an enantioenriched chiral common intermediate
that is first produced. From the common intermediate, it is possible to synthesize
multiple amino acid analogues through a series of well-known organic transformations
(Scheme 1).10-12

Scheme 1. Proposed synthesis of several classes of unnatural amino acids from a common
intermediate.
One of the most critical steps in the synthesis of the unnatural amino acids is hydrolysis
of the prochiral malonate with Pig Liver Esterase (PLE) to produce the enantioenriched
chiral intermediate. Often, PLE provides very high enantioselectivity and is relatively
inexpensive compared to other enzymes or chiral auxiliaries needed to perform the same
reaction. However, there are several substrates for which PLE provides low
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enantioselectivity, and very little is known why. Additionally, crude PLE is composed of
several individual isoenzymes, which further complicate the prediction of the
enantioselective outcome of the reaction.13,14 A mass spectrometry assay has been
developed to screen potential combinations of cosolvent and enzyme for high
enantioselectivity.15 This dissertation will focus on three main goals:


The attempts to better understand the role of cosolvent as well as the individual
isoenzymes in the PLE hydrolysis reaction;



The improvement of our previously reported mass spectrometry assay to
determine yield and enantioselectivity in a single assay;



The evaluation of an unnatural glutathione analogue for its stability against the
glutathione reductase enzyme.

Literature review
Over the past several years, the area of biocatalysis has grown in popularity.
Biocatalytic routes have been developed for various applications, including preparation
of herbicides, key organic intermediates, pharmaceuticals, and various other
applications.16,17 Enzymes are widely used in organic chemistry as a tool to prepare
chiral intermediates due to their relative low cost, stability, short reaction times, and high
selectivity. Additionally, enzymatic reactions traditionally take place in an aqueous
environment, resulting in a “green chemistry” route in the synthesis of various products.18
Recently, there have been many advances in biotechnology that have allowed enzymes to
be used more frequently in industrial settings.19
Pig Liver Esterase (PLE) has been used extensively in organic chemistry. 20-24
One of the most common applications of PLE is the kinetic resolution of racemic
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intermediates.20-24 During a kinetic resolution, PLE reacts with one enantiomer of the
racemic intermediate faster than the other. For example, during the hydrolysis of the
acetate in Scheme 2, the (R) alcohol is obtained by hydrolysis of the acetate. In this case,
the (R)-enantiomer is hydrolyzed at a faster rate than the (S)-enantiomer, leaving the (S)
enantiomer of the acetate left unchanged. The product and starting material can then be
separated by chromatographic or other techniques. However, kinetic resolution is an
inefficient process to obtain an enantioenriched product as the maximum reaction yield is
only 50%.

Scheme 2. Kinetic resolution of an acetate resulting in pure starting material (S)
enantiomer and pure product ((R) enantiomer).
PLE has been used as a strategy for the deprotection of ester moieties as well as in
the synthesis of key intermediates for natural products.25-34 Perhaps one of the most
common uses of PLE is the conversion of prochiral diesters into enantioenriched halfesters (Scheme 3).11,12,31,35-42

Scheme 3. Generic PLE hydrolysis reaction.
Interestingly, several groups have utilized PLE for the synthesis of unnatural
amino acids.10-12,15,36,38,42-48 Kedrowski produced both enantiomers of α-methyl cysteine
in overall good yield and enantioselectivity (97% ee both enantiomers). PLE catalyzed
desymmetrization of the diester produced the half-ester in good yield and
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enantioselectivity (91% ee, 97% yield). Subsequent Curtius rearrangement and amine
deprotection provided the (R)-α-methyl cysteine in two steps. The (S)-α-methyl cysteine
was obtained by first protecting the acid-ester with a tert-butyl protecting group, followed
by Curtius rearrangement (Scheme 4).42

Scheme 4. Synthesis of both enantiomers of -methyl cysteine by Kedrowski.
Several unnatural amino acid analogues were synthesized in a similar fashion by
Masterson et al. (Scheme 4).12 Methodology was developed to prepare both enantiomers
of α2,2-, β2,2-, and β3,3- cysteine and serine amino acids. The starting diethyl methyl
malonate was alkylated to produce the prochiral diester. The diester was then hydrolyzed
using PLE to prepare the chiral half-ester intermediate. Interestingly, the ethyl half ester
was obtained in 81% ee, whereas the methyl half ester was obtained in 91% ee.12,42 The
β2,2 unnatural cysteine amino acid was obtained through a Wolff/Curtius rearrangement
sequence of the acid-ester. Manipulation of the protecting groups, followed by a similar
series of steps produced the opposite enantiomer.
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Scheme 5. Synthesis of -(R)-cysteine by Masterson.12
Similar synthetic strategies to those discussed above have been employed to
produce analogues of amino acids including serine, tyrosine, lysine, proline, and several
others.10-12,15,38,46-48 Interestingly, the hydrolysis with Pig Liver Esterase provided
varying enantioselectivity as well as yields for all of the different substrates.
Enantioselectivity ranged from poor (45%) to excellent (>98%) (Table 1). However, in
each case the major enantiomer produced was the (R)-enantiomer. These results
highlight the difficulty in predicting the enantioselective outcome of the PLE hydrolysis
reaction.
Table 1
Varying enantioselectivity from PLE hydrolysis of various substrates.

1.
2.
3.
4.
5.
6.
7.
8.
9.
10.

R’
Me
Me
Me
Me
Et
Et
Et
Et
Et
Et

R”
-CH2St-Bu
-(CH2)5CH3
-Bn
-Ph
-CH2St-Bu
-CH2OBn
-CH2SiMe3
-CH2NPhth
-(CH2)2NPhth
-(CH2)3NPhth

% ee
91
67
45
>98
81
70
75
52
92
97

configuration
(R)
(R)
(R)
(R)
(R)
(R)
(R)
(R)
(R)
(R)

Reference
Kedrowski42
Iosub38
Bjorkling
Iosub38
Masterson12
Masterson12
Falgner47
Smith44
Banerjee10
Banerjee11
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Unnatural amino acids have gained significant interest over the past several years.
While there are many classes of unnatural amino acids, our main interest lies with the
α,α-disubstituted class of amino acids. α,α-disubstituted unnatural amino acids have an
additional R group that replaces the hydrogen atom in the carbon backbone of the amino
acid molecule (Figure 1). Several strategies exist to synthesize the unnatural amino
acids, including the previously discussed route through PLE hydrolysis.

Figure 1. Naturally occurring amino acid and unnatural amino acid.
Unnatural amino acids (UAA) have been used for several applications, including
foldamers, antiobiotics, as well as chiral auxiliaries and catalysts.49,50 UAAs have been
incorporated into peptides and proteins.51,52 Incorporation of α,α-disubstituted amino
acids into peptides cause increased chemical and metabolic stability and hydrophobicity
compared to naturally occurring peptides.53 Furthermore, the additional alkyl group
limits the conformational freedom of the side chains of the amino acid.53,54
One of the most well-known α,α-disubstituted amino acids is 2-aminoisobutyric
acid (Aib). Aib has a methyl group that replaces the hydrogen at the α position of the
amino acid (Figure 2). Incorporation of Aib into the antibiotic peptide BKBA-20 (Ac(Aib-Lys-Aib-Ala)5-NH2) greatly improved the proteolytic stability of the peptide.51
Furthermore, this analogue showed comparable antimicrobial activity to that of BKAA20 (Ac-(Aib-Lys-Ala-Ala)5-NH2). The peptides AKBA-20 (Ac-(Ala-Lys-Aib-Ala)5NH2) and AKAA-20 (Ac-(Ala-Lys-Ala-Ala)5-NH2) were not active. These results
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highlight two key points. First, the incorporation of unnatural amino acids are able to
improve the stability of the peptide against proteolytic degradation, and second, the
relative position of the unnatural amino acid affects the activity and stability of the
peptide.

Figure 2. Structure of Aib and analogues of the AKAA peptide.
Recently, an unnatural glutathione analogue that has the native cysteine replaced
with the alpha methyl cysteine analogue was synthesized.42,43 The (R)-α-methyl cysteine
analogue was synthesized as previously reported.42 Subsequent coupling and
deprotection steps provided the sulfide protected tripeptide. The tert-butyl protecting
group was removed using mercuric acetate to give the reduced glutathione analogue in
quantitative yield. The reduced glutathione analogue was oxidized to glutathione
disulfide by passing O2 through a basic solution of the peptide. The disulfide was
obtained in 12 steps in 21% yield overall starting from the tert-butyl mercaptan (Scheme
6).43

8

Scheme 6. Synthesis of an unnatural glutathione analogue containing -methyl cysteine.
Peptides are rapidly degraded due to the presence of proteases. Furthermore,
disulfide bonds also degrade rapidly in vivo due to the presence of reductases. However,
it has been illustrated that the incorporation of α,α-disubstituted amino acids into a
peptide can improve the stability of the peptide in vivo.9,50,55-58 For this reason, the
stability of an unnatural glutathione analogue should be improved against reductases by
incorporation of α-Me-cysteine.
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Hypotheses
Hypothesis 1 postulates that the enantioselectivity of Pig Liver Esterase
isoenzymes with various substrates can be “tuned” through the use of selected organic
cosolvent to produce enantiomerically enriched synthons. Chapter II will focus on the
attempts made to better understand the role of solvent and the individual isoenzyme in the
PLE hydrolysis reaction.
Hypothesis 2 postulates that an external standard that is chemically similar to the
substrate of interest can be added to the LC-MS samples and will enable us to obtain data
on both enantioselectivity and yield data from a single analysis. The efforts to develop a
mass spectrometry assay capable of determining yield and enantioselectivity in a single
analysis are discussed in Chapter III.
Disulfide bonds are known to rapidly degrade in vivo. Hypothesis 3 postulates
that peptides that have unnatural cysteine analogues incorporated may exhibit increased
stability in vivo against reductase enzymes. Chapter IV will discuss the evaluation of an
unnatural glutathione analogue for its stability against the glutathione reductase enzyme.
Chapter V will conclude this dissertation and offer some potential future directions for
each project.
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CHAPTER II
INTERACTIONS BETWEEN ENZYME, COSOLVENT, AND SUBSTRATE
IN THE PIG LIVER ESTERASE (PLE) HYDROLYSIS OF
SEVERAL MALONATE DIESTERS
Hypothesis 1
The enantioselectivity of Pig Liver Esterase isoenzymes with various substrates
can be “tuned” through the use of selected organic cosolvents to produce
enantiomerically enriched synthons.
Background
What is Pig Liver Esterase (PLE)?
One of the most synthetically useful enzymes is Pig Liver Esterase (PLE), a
serine-type esterase. PLE has been used in many applications in organic synthesis,
including kinetic resolutions,20,22,24,59-61 deprotection of functional groups,25,26,62 and the
preparation of intermediates for total synthesis.27 PLE is probably most well-known for
its ability to convert racemic esters into enantioenriched half-ester (Scheme 7).36,40,63,64

Scheme 7. Conversion of prochiral diester to enantioenriched half-ester through PLE
hydrolysis
Crude PLE is commercially available as a powder. The powder is prepared by
homogenizing fresh pig liver with cold acetone.65,66 Approximately 1 kg of crude
enzyme is isolated for every 4 kg of fresh pig liver.66 This commercially available PLE is
known to be composed of a mixture of at least six isoenzymes, and the composition of
the PLE varies from batch to batch.13,65
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Jones Active Site Model
While PLE has been used extensively in various applications, relatively little is
known about the active site and structure of the enzyme due to the lack of a crystal
structure. However, in 1990, Jones et al. proposed an active site model of PLE that has
proven useful in predicting the outcome of many hydrolysis reactions (Figure 3).67 This
active site model was proposed based on the analysis of more than 100 PLE catalyzed
hydrolyses of prochiral methyl and ethyl diester molecules.68,69 The Jones Active site
model consists of four pockets. The two binding pockets are denoted by PF and PB (polar
front and polar back, respectively). Additionally, there are two hydrophobic pockets,
denoted by HL and HS (hydrophobic large and hydrophobic small, respectively). The
active serine residue is thought to be located near the polar back (PB) pocket. The ester to
be hydrolyzed fits into the polar back pocket close to the active serine residue.70 The
remainder of the molecule will be oriented, so they adequately fill the remaining pockets.
Based upon the Jones active site model, aromatic or aliphatic portions of the substrate are
thought to best fit in the hydrophobic pockets of the enzyme. The hydrophobic pockets
typically do not allow polar groups, such as hydroxyl, amino, or nitro groups.67
However, this is just a general guideline, and several exceptions have been discovered.44

Figure 3. Jones Active Site Model. A generic substrate is fitted within the model.
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Although the Jones active site model has proven to be useful in predicting the
enantioselective outcome for many of the hydrolysis reactions, there are several
exceptions.71,72 The Jones active site model assumes all of the isoenzymes behave
similarly with respect to their enantioselectivity in the hydrolysis reaction.73 PLE is
composed of several isoenzymes, and the amount of each isoenzyme in the crude PLE
mixture can vary between batches. Finally, the active site model is based on the
hydrolysis in buffer; however, it is well documented that varying the organic content of
the reaction mixture alters the enantioselective outcome of the reaction.15,39,44,74,75
Although the Jones Active Site Model is the most common model, other models
of the PLE active site have been developed.23,76 While attempts at crystallization and
determination of the crystal structure of PLE have been unsuccessful, a homology model
of PLE has been developed to provide insight into the structure of the enzyme.76 The
homology model was based upon the sequences for human liver carboxyl esterase (hCE)
and rabbit liver esterase. PLE shares approximately 75% sequence homology with these
enzymes.76 The original model for PLE1 was modified by numerous mutations to obtain
models for the other isoenzymes of PLE, and the conformational effects of the mutations
were studied.76 These models help to further verify the Jones Active Site Model.
Recombinant PLE
The cloning and recombinant expression of a single isoenzyme of PLE in Pichia
pastoris was reported in 2001.77 This isoenzyme was referred to as recombinant PLE (rPLE), γ-PLE, or PLE 1 and is the first report of an individual isoenzyme of PLE being
cloned and isolated. The initial production of γ-PLE in Pichia pastoris produced only
small amounts of enzyme. The yield was improved by cloning the enzyme in E. coli.78
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The enantioselectivity of r-PLE was found to be considerably different from
commercial PLE (Table 2).79,80 The variations in enantioselectivity were attributed to the
fact that the rPLE sample consisted of only one isoenzyme, while the commercially
available PLE samples were composed of the various isoenzymes in varying amounts.80
For example, rPLE showed higher enantioselectivities compared to commercially
available enzyme in the kinetic resolution of (R,S)-1-phenyl-2-pentyl acetate (Table 2).80
Table 2
Comparison of enantioselectivity of recombinant PLE (rPLE) to commercial sources.80

1.
2.
3.
4.
5.

PLE source
r-PLE
Fluka
Sigma
Chirazyme 1
Chirazyme 2

Time (h)
2
0.3
0.5
0.5
0.3

% ee (R)
69
24
15
9
21

% ee (S)
78
26
13
11
24

% conversion
47
48
52
46
46

E
16.7
2.1
1.5
1.3
2

The ability to clone rPLE prompted an interest in identifying and cloning the
other isoenzymes of PLE. Two PLE variants, α-PLE and β-PLE, were separated from the
crude PLE mixture by two dimensional (2D) gel electrophoresis. Separation of the PLE
proteins was accomplished in the first dimension by using isoelectric focusing and in the
second dimension by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDSPAGE).81 The two PLE variants were digested with proteases, and the fragments
analyzed by matrix assisted laser desorption ionization (MALDI) time-of-flight (TOF)
and electrospray ionization quadrupole time-of-flight (ESI-Q-TOF) mass spectrometry.81
Although the exact amino acid sequences of the variants were not determined at this
point, Brusehaber et al. noticed there were variations in the amino acids in the three
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isoenzymes of PLE (α, β, γ).78 It was believed that these variations in the amino acid
sequences led to the differences in enantiopreference among the isoenzymes.81,82
Isoenzymes of PLE
It has been well known that PLE is composed of several isoenzymes.13,14,83,84
However, it was not until 2007 that Hummel et al. reported success in cloning all six
individual isoenzymes in E. coli.21 The isoenzymes differ in isoelectric point, molecular
weight, sensitivity towards inhibitors, and substrate specificity.14,21 It was found that
much of the amino sequence is conserved between strands with variations occurring at
certain parts of the strands (Figure 4).73 Black regions represent areas conserved in all
the isoenzymes of PLE. PLE 1 and 2 had the same sequence, except for the region
between amino acids 459-463. Conversely, the amino acid sequences in PLE 1 and 6 are
not conserved in any of the highlighted regions. It was noted that the areas that contained
the catalytic triad were conserved for all of the enzymes.73

Figure 4. Sequences of the PLE isoenzymes. Areas in black represent homology
between the strands. Different colors represent differences in the sequences.
In addition to having different amino acid sequences, the isoenzymes were found
to exhibit different enantioselectivities (Figure 5).21 For example, in the kinetic
resolution of a secondary alcohol, PLE isoenzymes 1 and 2 showed similar
enantioselectivity to one another. The amino acid sequences of PLE 1 and PLE 2 differ
by only three amino acids. However, PLE isoenzymes 3-5, which differ from PLE 1 in
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amino acid sequence by up to 21 residues, displayed very different enantioselectivity
from PLE 1. It is interesting also to note that each of the individual isoenzymes of PLE
showed much higher enantioselectivity than that of the commercially available PLE
(Figure 5).21

Figure 5. Kinetic resolution of several acetates with the isoenzymes of PLE.21 In all
cases, the isoenzymes provided higher enantioselectivity than the commercially available
PLE from Fluka. Interestingly, PLE 4 and PLE 5 produced the (R)-alcohol as the
predominant enantiomer in all cases.
Reaction Medium Engineering.
Typical PLE reactions take place in an aqueous buffer solution at a pH in the
range of 7.0-8.0. However, it has been reported that the enantioselective outcome of the
enzymes can be tuned through the modification of the reaction medium, known as
reaction medium engineering.15,40,44,75,85-89 Typical cosolvents have been alcohols, such
as MeOH, EtOH, i-PrOH, and t-BuOH, as well as non-nucleophilic solvents, such as
THF, MeCN, and DMSO. Masterson has shown that the addition of 10% i-PrOH
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cosolvent to the crude PLE hydrolysis reaction of a prochiral diethyl malonate was able
to improve the enantioselectivity from 70% to >97% ee (Scheme 8).15 Other cosolvents,
such as DMSO, DMF, or MeCN, were not shown to improve the enantioselectivity of the
reaction to the same extent, even with the addition of up to 30% cosolvent.

Scheme 8. PLE catalyzed hydrolysis of prochiral diethyl malonate resulting in >97% ee.
Guanti showed that several cosolvents were able to influence the
enantioselectivity of the PLE hydrolysis of a meso diacetate.75 The product was
produced in 55% ee in the absence of cosolvent. The highest enantioselectivity was
achieved with the addition of 10% t-BuOH to the reaction.75 However, it should be noted
that in some examples, up to 40% cosolvent was needed to significantly improve the
enantioselectivity of the reaction. In addition to altering the % ee of the reaction,
addition of the cosolvent decreased the reaction rate but improved the yield of the
reaction (Table 3).75
Table 3
Hydrolysis of a meso-diacetate with crude PLE and various cosolvents.75

1.
2.
3.

Reaction condition
H2O
20% DMSO
40% DMSO

Relative rate
(to reaction in
H2O)

Yield

% ee

1
0.7
0.28

60
62
72

55
59
72
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Table 3 (Continued).

Reaction condition
20% DMF
5% t-BuOH
10% t-BuOH

4.
5.
6.

Relative rate
(to reaction in
H2O)

Yield

% ee

0.35
0.7
0.44

74
76
78

84
94
96

Why PLE?
As illustrated, PLE has several advantages and is a very useful enzyme. First,
PLE is very inexpensive in comparison to other similar enzymes, such as rabbit liver
esterase or α-chymotrypsin (Table 4). PLE is stable as a powder and can be stored in the
refrigerator without noticeable loss of activity. Chiral intermediates can be prepared
from PLE in high enantioselectivity and high yield eliminating the need for expensive
chiral auxiliaries. PLE reactions take place in aqueous buffer solution avoiding the use
of large amounts of organic solvent. This makes PLE reactions more environmentally
friendly than reactions taking place in organic solvents. Finally, PLE can accept a wide
range of substrates and is a very versatile enzyme.
Table 4
Comparison of prices per unit of enzyme for various hydrolase enzymes. (prices retrieved
6/6/2014 from Aldrich.com or Worthington.com)
1.
2.
3.
4.

Enzyme sample
Pig Liver Esterase (PLE)
Rabbit Liver Esterase (RLE)
Lipase, Candida Antarctica
α-chymotrypsin

Manufacturer
Aldrich
Aldrich
Aldrich
Worthington

Note. Prices retrieved 6/6/2014 from Alrich.com or Worthington.com

Cost per unit enzyme($)
$0.000024/unit
$0.26/unit
$0.52/unit
$0.0105/unit
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Limitations of PLE
Although PLE has many favorable qualities, several factors decrease the synthetic
utility of PLE. Because PLE is produced from a pig, any products resulting from use of
PLE would not be considered kosher. Commercially available crude PLE is a mixture of
each of the isoenzymes in varying amounts, so the composition of PLE can vary from
batch to batch making the enantioselectivities of the reactions hard to precisely predict.
Addition of organic cosolvent to the hydrolysis reactions is able to alter the
enantioselectivity of the reaction, again making the enantioselective outcome of the
reaction hard to predict. Finally, many substrates provide poor enantioselectivity or
yield.
There are still several questions needing to be answered regarding the structure of
PLE. The crystal structure of PLE has not yet been obtained. Even less is known about
the enantioselectivity of the individual isoenzymes of PLE.21,44,73 Furthermore, it is
unclear how various cosolvents influence the enantioselective outcome of the individual
PLE isoenzyme. To gain a better understanding of how the isoenzymes function within
the crude mixture, we have chosen to evaluate hydrolysis reactions of several prochiral
diesters. By evaluating the products of the hydrolysis reaction, we can provide insight
into the factors that influence the enantioselective outcome of the hydrolysis reaction.
These reactions will allow us to make suggestions about the Jones Active Site Model and
help to improve our understanding of the PLE active site.
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Results and Discussion
Initially, the hydrolysis of three diesters with PLE and various cosolvents was studied.
These three diesters were chosen because they are all precursor molecules used to
synthesize unnatural amino acids.
Hydrolysis of 1 with crude PLE, PLE isoenzymes and EtOH cosolvent
Hydrolysis of 1 was performed with crude PLE, each isoenzyme and varying
amounts of EtOH cosolvent to gain a better understanding of the effect of the EtOH
cosolvent (Scheme 9). EtOH was chosen because other alcohols, such as iso-propanol,
had proven to be successful in increasing the enantioselectivity of the PLE hydrolysis
reaction.15 However, the EtOH was not a compatible cosolvent with our previously
reported mass spectrometry assay due to loss of the deuterium label.15 Instead, the
products of the hydrolysis reaction of 1 were analyzed using chiral chromatography
coupled with atmospheric pressure chemical ionization (APCI) mass spectrometry. The
chiral column was directly coupled to the mass spectrometer to determine the
enantioselectivity of the hydrolysis reaction.

Scheme 9. Hydrolysis of 1 with EtOH and PLE (crude or isoenzymes).
The hydrolysis of 1 with crude PLE provided low enantioselectivity of only 23%
ee ((R) enantiomer). However, upon addition of just 2% (v/v) EtOH cosolvent to the
reaction, the enantioselectivity was dramatically improved (78% ee, (R) enantiomer).
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Addition of up to 14% EtOH (v/v) did not further improve the enantioselectivity.
Interestingly, isoenzymes 1 and 2 provided high enantioselectivity in the absence of
cosolvent (87% and 78%, respectively; (R) enantiomer). PLE 1 and PLE 2 provided
much higher enantioselectivity compared to that of crude PLE. The improvement in
enantioselectivity can be attributed to the isoenzyme being a single, pure enzyme, while
crude PLE is a mixture of the isoenzymes in various compositions. The addition of 2%
EtOH to the hydrolysis reaction with PLE 1 improved the enantioselectivity to 95 % ee,
((R) enantiomer). Additional EtOH did not improve the enantioselectivity further.
Hydrolysis of 1 with PLE 2 and 2% EtOH produced the (R) enantiomer in 89% ee.
Further addition in EtOH (up to 14%) resulted in decreased enantioselectivity (Figure 6).
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Figure 6. Results of PLE hydrolysis assay with 1 and EtOH cosolvent. Negative % ee
denotes (S)-enantiomer predominantly. Positive % ee denotes (R)-enantiomer
predominantly. (Figure originally published in ChemCatChem.44)
Interestingly, hydrolysis of 1 with PLE isoenzymes 3-6 produced predominantly
the (S)-enantiomer in the absence of EtOH. PLE 4 and PLE 5 produced the highest
enantioselectivities with approximately 59% ee ((S) enantiomer). Hydrolysis of 1 with
PLE 6 produced a moderate enantioselectivity of 53% (S) enantiomer, while PLE 3
produced the (S) enantiomer predominantly in 29% ee. Interestingly, solvent induced
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inversion of enantioselectivity was observed upon addition of EtOH cosolvent to the
hydrolysis reactions with PLE 3-6. The largest inversion of stereochemistry was
observed with the addition of 2% EtOH cosolvent to the hydrolysis reaction with PLE 6.
In the absence of cosolvent, hydrolysis of 1 with PLE 6 provided the (S) enantiomer in
53% ee. The addition of 10% EtOH cosolvent to the hydrolysis reaction provided the (R)
enantiomer in 50% ee (Figure 7).

Figure 7. Solvent induced inversion of chirality. Top panel: 2 prepared from hydrolysis
with isoenzyme 6 (0% (v/v) EtOH cosolvent) (S)-enantiomer 35.14 minutes, (R)enantiomer 51.39 minutes. Bottom panel: 2 prepared from hydrolysis with isoenzyme 6
(10% (v/v) EtOH cosolvent, (S)-enantiomer 36.12 minutes, (R)-enantiomer 52.13
minutes. (Figure originally published in ChemCatChem.44 Reproduced with permission
from John Wiley and Sons.)
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Hydrolysis of 1 with PLE and non-nucleophilic cosolvents
The effect of various non-nucleophilic cosolvents in the crude PLE hydrolysis
with 1 was studied using our previously reported mass spectrometry assay (Scheme 10).15

Scheme 10. PLE hydrolysis assay of probe-1 with non-nucleophilic cosolvents.
The chosen cosolvents had been previously reported to alter the enantioselectivity
of PLE hydrolysis reactions.15 Many of the cosolvents chosen for this assay appeared to
decrease the enantioselectivity of the reaction, with the exception of i-PrOH and DMF.
Upon the addition of just 2% i-PrOH to the hydrolysis reaction with crude PLE, the
enantioselectivity was improved from 23% ee (R)-enantiomer to 48% ee (R)-enantiomer.
Further addition of i-PrOH to the reaction was not able to improve the enantioselectivity.
The other non-nucleophilic cosolvents were not able to improve the enantioselectivity to
an appreciable extent, and some even had a deleterious effect (Figure 8).
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Figure 8. Results of PLE hydrolysis assay with probe-1 and non-nucleophilic cosolvents.
Negative % ee denotes (S)-enantiopreference. Positive % ee denotes (R)enantiopreference. (Figure originally published in ChemCatChem.44)
Because improvements in enantioselectivity were observed with crude PLE and iPrOH, a hydrolysis assay was performed with individual isoenzymes and i-PrOH.
Interestingly, hydrolysis of 1 with the isoenzymes of PLE showed a similar trend in the
enantioselective outcome for the addition of i-PrOH as compared to the addition of EtOH
cosolvent. However, the extent of enhancement of enantioselectivity was not as dramatic
when i-PrOH cosolvent was added as compared to EtOH. Crude PLE and PLE 2 showed
minor improvements in enantioselectivity upon addition of 2% i-PrOH. PLE isoenzymes
3-6 all became increasingly more (R) selective upon the addition of i-PrOH cosolvent to
the reaction. However, the extent of inversion was not nearly as large as with EtOH
(Figure 9).

24

100

% ee

50

0
5

10

15

Crude PLE
PLE 1
PLE 2
PLE 3
PLE 4
PLE 5
PLE 6

-50

% i-PrOH

Figure 9. Results of PLE hydrolysis assay of 1 and i-PrOH cosolvent. Negative % ee
denotes (S)-enantiopreference. Positive % ee denotes (R)-enantiopreference. (Figure
originally published in ChemCatChem.44)
Hydrolysis of 3 with PLE and EtOH
Next, the PLE hydrolysis assay of substrate 3 was performed in the presence and
absence of EtOH cosolvent (Scheme 11). Ethanol was able to alter the enantioselectivity
of the hydrolysis reaction of 3. However, it should be noted that the magnitude of the
effect was not nearly as significant as with substrate 1 and EtOH.

Scheme 11. Hydrolysis of 3 with EtOH and PLE (crude or isoenzymes).
Interestingly, each of the isoenzymes produced predominantly the (R)-enantiomer
in the hydrolysis reaction. Only moderate improvement to the enantioselectivity of the
hydrolysis reactions was observed upon addition of EtOH. The hydrolysis of 3 with
crude PLE was improved from 63% ee (R) to 83% ee (R). The largest improvements in
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enantioselectivity were observed for reactions using PLE isoenzyme 6. The hydrolysis of
3 improved from 63 % ee (no cosolvent) to 81% ee (2% EtOH). Many of the other
isoenzymes only showed small improvements to the enantioselectivity upon addition of
EtOH to the hydrolysis reactions. PLE 2 and PLE 5 also showed slight decreases in
enantioselectivity upon the addition of 2% EtOH to the hydrolysis reactions (Figure 10).
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Figure 10. Results of PLE hydrolysis assay with 3 and EtOH cosolvent. Negative % ee
denotes (S)-enantiomer predominantly. Positive % ee denotes (R)-enantiomer
predominantly. (Figure originally published in ChemCatChem44)
The hydrolysis of 3 was also performed with i-PrOH. A similar trend in
enantioselectivities was observed as with EtOH. Only slight improvement to the
enantioselectivity was observed upon addition of i-PrOH to the crude PLE reaction (63%
ee to 69% ee, (R) enantiomer) (Figure 11).
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Figure 11. Results of PLE hydrolysis assay with 3 and i-PrOH cosolvent. Negative % ee
denotes (S)-enantiomer predominantly. Positive % ee denotes (R)-enantiomer
predominantly. (Figure originally published in ChemCatChem.44)
Hydrolysis of 5 with Crude PLE and PLE isoenzymes and EtOH
Next, the hydrolysis assay of 5 was performed in the presence and absence of
EtOH. In the hydrolysis of substrates 1 and 3, both substrates contain a hydrogen bond
acceptor group in the side chain of the molecule. Substrate 5 was chosen as it does not
contain a hydrogen bonding atom in the side chain (Scheme 12). The hydrolysis of 5
with varying EtOH content was explored as it proved to be the best cosolvent for
substrates 1 and 3.

Scheme 12. Hydrolysis of 5 with EtOH and PLE (crude or isoenzymes).
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The crude PLE hydrolysis of 5 typically provides poor enantioselectivity. Upon
hydrolysis of 5 with crude PLE, the product was produced as a racemic mixture. The
enantioselectivity was slightly improved to 10% ee upon the addition of 2% EtOH to the
hydrolysis reaction. The highest enantioselectivity of 17% ee was achieved by the
addition of 10% EtOH to the hydrolysis reaction (Figure 12).
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Figure 12. Results of PLE hydrolysis assay with 5 and EtOH cosolvent. Negative % ee
denotes (S)-enantiomer predominantly. Positive % ee denotes (R)-enantiomer
predominantly. (Figure originally published in ChemCatChem.44)
Upon hydrolysis of 5 without cosolvent PLE, isoenzymes 1 and 2 provided the
product in nearly racemic form, whereas in the other two reactions these isoenzymes
provided the (R) enantiomer. Interestingly, PLE 3 and PLE 4 provided the (R)
enantiomer predominantly in the hydrolysis of 5 but the (S) enantiomer predominantly in
the hydrolysis of 1 in the absence of cosolvent. These results highlight the difficulty in
predicting the stereochemical outcome of PLE hydrolysis reactions. Interestingly, the
addition of ethanol to the hydrolysis reaction of 5 did not improve the enantioselectivity
of the hydrolysis reactions to any appreciable extent.
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Exploration of hydrogen bonding
Based on these results, it was clear that each of the substrates displays very
different enantioselectivities with the various isoenzymes. In addition, EtOH influenced
the enantioselectivity of the hydrolysis reactions to different extents. The ability of the
EtOH cosolvent to influence the reaction may be dependent on the hydrogen bonding
ability of the side chain. Ethanol or iso-propanol has a stronger influence in the
stereochemical outcome of hydrolysis reactions of the substrates containing hydrogen
bond accepting atoms due to some ethanol-substrate complex being formed by hydrogen
bonding.
A series of 13C-NMR titrations were performed in order to better understand the
relationship between the substrate and ethanol. Deuterated chloroform (CDCl3) was used
as the solvent as a model for the NMR titrations. CDCl3 was chosen as it is less polar
than water and can serve as a representation of the hydrophobic pocket of the active site
of PLE. For each titration, a substrate solution was prepared (in CDCl3) along with a
separate solution of EtOH in CDCl3. A 13C-NMR spectra was recorded at several ratios
of substrate-ethanol concentrations. The chemical shifts for signals located nearest to the
hydrogen bonding atoms were recorded. An equilibrium constant was calculated for each
substrate according to the method of Hirose.90 For our purposes, the substrate was
considered the “host,” while the EtOH was considered the “guest.”

Scheme 13. Equilibrium for the substrate binding with EtOH.
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Equilibrium constants with substrates and Ethanol
As discussed, ethanol was able to influence the stereochemical outcome of the
PLE hydrolysis reaction with two of the substrates. NMR titrations were performed to
gain a better understanding of the extent of the interaction occurring between the
substrate and ethanol. For each substrate, the chemical shift of the indicated carbon
signal was recorded at various substrate-ethanol concentrations. The chemical shift for
the phthalimide carbonyl carbon was monitored as a function of ethanol concentration for
substrate 1 (Figure 13).

30

Figure 13. 13C-NMR spectrum for 1-EtOH titration in CDCl3. Bottom: Stack plot
highlighting carbon signals of interest shifting downfield as EtOH is added.
As evident in Figure 13, there was a downfield shift of the carbonyl signal as
EtOH was titrated into the solution. An equilibrium constant was calculated for the
interaction between substrate and EtOH using the chemical shift of the carbonyl signal as
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well as the concentrations of the EtOH solution and substrate solution. The equilibrium
constant was calculated based upon the following equations.90
1
1 2
([𝐻]𝑡 + [𝐺]𝑡 + ) ± √([𝐻]𝑡 + [𝐺]𝑡 + ) − 4 ∙ [𝐻]𝑡 ∙ [𝐺]𝑡
[𝐶]
𝑏
𝑏
𝑦= 𝑎∙
=
[𝐻]𝑡
2 ∙ [𝐻]𝑡
[𝐻]𝑡 =
[𝐺]𝑡 =

𝑝∙𝑞
𝑠+𝑞

𝑟∙𝑠
=𝑥
𝑠+𝑞

The variables for the above equations are defined as follows:
[H]t: total host at initial stage
[G]t: total guest at initial stage
[C]: concentration of complex at final stage (equilibrium)
p: concentration of host solution
q: amount of host solution
r: concentration of guest solution
s: amount of guest solution
a: ch (chemical shift of complexed host – chemical shift of host part in free)
b: K (equilibrium constant)
At each point in the titration, the observed chemical shift for the signal of interest
was recorded. The chemical shift was entered into a spreadsheet program developed by
Hirose.90 The spreadsheet program contained the equations above and was used to
calculate the equilibrium constant for each titration. The concentrations of the host
(substrate) and guest (ethanol) solutions were entered into the program along with the
volume used of each solution. The SOLVER function of Excel® was used to minimize
the sum of squares deviations for the titration data, which allowed for the calculation of
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c (shift of complexed host) as well as the equilibrium constant (K) for each titration.90
Each titration was performed three times, and an equilibrium constant was calculated for
each titration. The average of the three equilibrium constants was determined and
reported with the standard deviation between the three values.
The relative strength of the equilibrium constant could be assessed based upon the
equation for equilibrium constants. Larger values indicated that the concentration of the
substrate-EtOH complex was higher than the concentrations of the individual species. A
larger Keq value was therefore taken to mean that the substrate was able to form strong
hydrogen bonds. In comparison, smaller values indicated that the concentrations of the
individual species were greater than the concentration of the substrate-EtOH complex. A
smaller Keq value meant that hydrogen bonds did not form well. All of the equilibrium
constants are expressed in M-1 based upon the generic equation for an equilibrium
reaction shown below.
𝐾=

[𝑠𝑢𝑏𝑠𝑡𝑟𝑎𝑡𝑒−𝐸𝑡𝑂𝐻]
[𝑠𝑢𝑏𝑠𝑡𝑟𝑎𝑡𝑒][𝐸𝑡𝑂𝐻]

The equilibrium constant for the phthalimide carbonyl of substrate 1 and EtOH
was determined to be 0.448 ± 0.04 M-1. The signal for the malonate carbonyl was also
shifted downfield, indicating an interaction between the malonate carbonyl and EtOH.
This interaction was expected; however, each substrate malonate exhibited nearly the
same interaction with EtOH. An equilibrium constant for the malonate carbonyl-EtOH
was calculated to be 0.326 ± 0.09 M-1. This equilibrium value for the malonate carbonyl
and EtOH was consistent for each of the substrates.
The same titration experiments were performed for 3 and 5 with EtOH. The
equilibrium constant for 3-EtOH was 0.196 ± 0.08 M-1. The equilibrium constant for 5-
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EtOH was 0.055 ± 0.01 M-1. The equilibrium constants for all three substrates indicate
that by typical convention, the interaction between ethanol and the substrate is a weak
interaction. Typically, a Keq value that is greater than 1 M-1 indicates that at equilibrium
the reaction is product favored. Conversely, a Keq value that is less than 1 M-1 at
equilibrium indicates the reaction is reactant favored.91 However, the calculated
equilibrium constants were used to gauge the strength of the interaction relative to one
another. In this series, substrate 1 had carbonyl groups capable of hydrogen bonding and
displayed the largest equilibrium constant. Conversely, 5, which has no atoms typically
capable of hydrogen bonding in the side chain, displayed a much lower equilibrium
constant. These results indicated there are more interactions occurring with 1-EtOH
rather than 5-EtOH, which was predicted (Figure 14).
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Figure 14. Equilibrium constants calculated for 1, 3, and 5 with EtOH.
The same NMR experiments were performed with the substrates and i-PrOH.
The equilibrium constant for 1-i-PrOH was calculated as 0.195 ± 0.07 M-1. Again, the
malonate carbon displayed binding with i-PrOH, however, the extent of binding was
consistent for all 3 substrates (0.150 ± 0.03 M-1). The equilibrium constant for 3-i-PrOH
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was 0.089 ± 0.01 M-1. The equilibrium constant for 5-i-PrOH was 0.007 ± 0.01 M-1
(Figure 15). Like the equilibrium constants determined with ethanol, substrates
containing more atoms capable of forming hydrogen bonds displayed larger equilibrium
constants. However, interactions between the substrates and i-PrOH are much weaker
than those between the substrates and EtOH. This is indicated by the magnitude of the
equilibrium constant. For instance, 1-EtOH produced a value of 0.448 ± 0.04 M-1, where
1-i-PrOH produced a value of 0.195 ± 0.07 M-1, indicating a much stronger interaction
between substrate 1 and EtOH.
0.5
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Figure 15. Equilibrium constants calculated for substrates 1, 3, and 5 with i-PrOH.
Based on these NMR experiments, EtOH interacts more strongly with molecules
containing atoms capable of hydrogen bonding in the side chains. The equilibrium
constants indicate the relative strength of the interaction. Substrates that have stronger
interactions with the cosolvent should be influenced more in the PLE hydrolysis
reactions.
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Correlation between change in % ee and Keq
Based on the results of the PLE hydrolysis reaction and NMR titration, it
appeared there was a correlation between the Keq and the amount that ethanol influenced
the hydrolysis reaction (Figure 16). Substrate 1 had the largest Keq and was also
influenced the most by the addition of EtOH to the hydrolysis reaction. Conversely,
substrate 5 showed very little binding to ethanol, and the enantioselectivity of the
hydrolysis reaction was not greatly improved upon the addition of 2% EtOH to the
reaction. Figure 16 displays the relationship between Keq and Δ % ee. The Δ % ee was
calculated by taking the % ee value obtained by hydrolysis with 0% EtOH and
subtracting it from the % ee value obtained by hydrolysis with 2% EtOH.
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Figure 16. Correlation between Keq and Δ % ee for three substrates. The green point
represents substrate 5, the blue point represents substrate 3, and the red point represents
substrate 1. Δ % ee is defined as the % ee of the hydrolysis reaction with 2% EtOH
added minus the % ee of the hydrolysis reaction with O% EtOH.
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Further Investigation of hydrogen bonding hypothesis
To further investigate the hydrogen bonding theory, a second series of substrates
was synthesized. The second series of substrates were all structurally similar to the first
series; however, the atoms capable of hydrogen bonding were altered. By altering the
hydrogen bonding capability of the side chain, without much alteration to the overall size
of the substrate, we can observe how these changes affect the interaction between
substrate and ethanol.
Synthesis of second series of substrates
Substrate 1 was converted to 7 as sulfur is not able to not form hydrogen bonds as
strongly as oxygen.92,93 Molecule 7 was synthesized by reaction of 1 with Lawesson’s
reagent (Scheme 14). Lawesson’s reagent has been used selectively to convert the
carbonyl of an amide to a thioamide in the presence of ester functionality.94 In this
reaction, the desired product (7) was synthesized as well as a mono-thiolated amide
product (8). The mixture of 7 and 8 were separated using column chromatography.

Scheme 14. Synthesis of substrate 7 with Lawesson’s reagent.
An analogue of substrate 3 containing a sulfur atom was synthesized. Sulfur does
not form hydrogen bonds as well as oxygen, so replacing the oxygen with a sulfur atom
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should cause a decrease in the influence that EtOH can play in the hydrolysis reaction.
Synthesis of 10 was completed using a similar procedure reported by Heinrich et al.95
The enolate of diethylmethyl malonate was generated using sodium hydride. Alkylation
with 9 produced the desired diester (10) in 73% yield (Scheme 15).

Scheme 15. Synthesis of 10.
Lastly, substrates 12a-c, analogues of substrate 5, were synthesized. Substrates
12a-c introduce a nitrogen atom into the ring (Scheme 16). Nitrogen forms stronger
hydrogen bonds than carbon atoms due to the electronegativity of the nitrogen atom.91
Analogues 12b and 12c were also synthesized to determine if the position of the nitrogen
atom within the ring altered the enantioselectivity of the PLE hydrolysis reaction.

Scheme 16. Synthesis of 12a-c.
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The diester synthesis was completed in two steps. First, the desired alkylating
agent was synthesized by reaction of the pyridine methanol with thionyl chloride (SOCl2)
to give 11a-c. Diethyl methyl malonate was added dropwise to a suspension of NaH in
dry THF, followed by alkylation with 11 to produce diester (12) (Scheme 16). The
synthesis of the alkylating agent proved to be quite difficult. Once neutralized, 11 rapidly
polymerizes at room temperature and must be used in the alkylation reaction very
quickly. Additionally, during the synthesis of 12, a side product was formed that could
not be isolated from the desired product. However, based upon mass spectrometry and
NMR data, the side product is formed in very low quantities amounts, and for the purpose
of this dissertation, was not of concern. The side product was most likely monoester
product, resulting from the decarboxylation of one of the esters of the diester of 12.
NMR titrations for 2nd substrate series
NMR titration experiments were performed for analogues 7, 10, and 12a-c. An
NMR titration experiment was performed for 7-EtOH. The thioamide shift was
monitored as a function of EtOH concentration. The equilibrium constant for the
interaction of substrate 7 and EtOH was 0.143 ± 0.041 M-1. In comparison, the Keq for
substrate 1 and EtOH was 0.448 M-1. These results indicate that replacement of the
oxygen atom of the amide carbonyl with a sulfur atom caused a decrease in the ability of
hydrogen bonds to form. Based on these equilibrium values, analogue 7 does not form
hydrogen bonds as well as 1. This indicates that addition of EtOH to the hydrolysis
reaction of 7 should not have a large influence on the enantioselective outcome of the
reaction.

39
An NMR titration was performed with 10 and EtOH. The equilibrium constant
was calculated to be 0.04 ± 0.03 M-1 for 10-EtOH. A large decrease in equilibrium
constant was observed for 10-EtOH in comparison to 3-EtOH (0.089 ± 0.01 M-1),
indicating that 3 is better able to form hydrogen bonds with EtOH. Because 3 forms
better hydrogen bonds than 10, the magnitude that EtOH will influence the PLE
hydrolysis reaction should be greater for 3 than 10.
13

C-NMR titrations were performed with 12a-c and EtOH.

The shifts for the

signals of the carbon atoms in the pyridine ring were monitored, recorded, and used to
calculate equilibrium constants. The shift of carbon signal “c” was monitored for all
three pyridine diesters (Figure 17). In all 3 cases, the equilibrium constants were similar.
For 12a-EtOH, the equilibrium constant was calculated to be 0.67 M-1 ± 0.09. For 12bEtOH, the equilibrium constant was calculated to be 0.629 ± 0.06 M-1, while the
equilibrium constant for 12c-EtOH was calculated to be 0.74 ± 0.04 M-1. These
equilibrium values are very large in comparison to the equilibrium constants calculated
for other substrates. The equilibrium constants calculated for 12-EtOH are much larger
than those calculated for 5-EtOH, indicating that the nitrogen atom is better able to form
hydrogen bonds than the carbon atoms.

Figure 17. Carbon atom monitored for analogues 12a-c. The carbon of the ring bearing
the benzyl carbon, labeled carbon “c” above, was monitored in each titration.
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Summary of NMR titration results
NMR titrations were completed for each of the substrates (Figure 18). The
equilibrium constant was measured with ethanol. As hypothesized, altering the hydrogen
bonding ability of the substrate caused a decrease in Keq for substrates 7 and 10, or an
increase in Keq for substrate 12a-c. If there is a correlation between Keq and the change in
% ee, it is expected that the hydrolysis of 7 and 10 would be less influenced by the
addition of EtOH than the hydrolysis of 12a-c.
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Figure 18. Summary of NMR titration results with EtOH.
PLE hydrolysis
A crude PLE hydrolysis was attempted with 7 (Scheme 17). However, under
typical reaction conditions in pH 7.4 phosphate buffer, the hydrolysis did not occur.
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Scheme 17. Hydrolysis of 7 using crude PLE. Under typical reaction conditions, the
hydrolysis did not occur.
Initially, it was thought that the substrate 7 was inhibiting crude PLE. A paranitrophenyl acetate (pNPA) assay was performed to test if this substrate was inhibiting
crude PLE.96 In the absence of enzyme, hydrolysis of the pNPA in buffer was not
observed, shown by the red line in Figure 19. However, when an aliquot of the reaction
mixture was taken and added to the assay, hydrolysis of the pNPA was still observed.
Because the pNPA was hydrolyzed in the presence of the substrate, the PLE enzyme was
still active, and 7 was not inhibiting the enzyme, shown by the blue line in Figure 19.
Based on the results of this experiment, it was concluded that 7 was not an inhibitor for
crude PLE. However, 7 was not a substrate for the crude PLE enzyme under typical
reaction conditions.
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Figure 19. Results of pNPA assay. The red line represents background hydrolysis (no
enzyme present). The blue line represents the pNPA assay in the presence of reaction
mixture containing 7 and crude PLE. The increase in slope of the blue line indicates that
hydrolysis of pNPA occurs in the presence of 7.
Since crude PLE was not able to hydrolyze 7, it was thought that the two sulfur
atoms caused 7 to be too insoluble in the buffer. Next, a crude PLE hydrolysis was
attempted with 8 (Scheme 18). Diester 8 only has one of the oxygen atoms of the
phthalimide group replaced with a sulfur atom, so it was thought that this diester would
be more soluble in buffer. However, 8 was not hydrolyzed using standard hydrolysis
conditions.
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Scheme 18. Hydrolysis of 8 using crude PLE.
Although 1, 7, and 8 were only slightly different from one another, the sulfur
atoms had an influence on the outcome of the hydrolysis reaction. When diester 7 or 8
was added to the buffer, the diester did not disperse into the buffer very well. Most of the
diester became stuck to the beaker. Further experiments were not performed with 7 and 8
because no hydrolysis occurred with crude PLE.
A PLE hydrolysis reaction was performed on 10 using crude PLE to produce the
half-ester 15. However, direct measurement of the enantioselectivity of the reaction was
not possible due to overlapping retention times in chiral HPLC. In order to determine the
enantioselectivity of the reaction, the half-ester 15 was converted to the benzyl-ethyl
diester 16 (Scheme 19). The enantiomers of 16 were resolvable by chiral HPLC.

Scheme 19. PLE hydrolysis of 10 to produce 15. Half-ester 15 was then protected using
benzyl bromide to give 18.
Substrate 10 was hydrolyzed with crude PLE to produce 15 in approximately 58%
ee. Upon addition of EtOH to the hydrolysis reaction of 10, a slight improvement was
observed for the % ee (63%). This lead to a 5% increase in enantioselectivity for 10
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when 2% EtOH was added to the reaction, whereas a 20% increase in enantioselectivity
was observed with 3 under the same conditions. These results further confirm that
substrates that are able to hydrogen bond better are influenced more by the addition of
EtOH to the hydrolysis reactions.
The hydrolysis reactions of 10 with the PLE isoenzymes were also performed.
All 6 isoenzymes produced the (R)-enantiomer as the major product. PLE 1 and 2
provided the (R) enantiomer in the highest enantioselectivity (81% and 89%,
respectively). However, further enhancement of enantioselectivity was not observed
upon addition of 2% EtOH cosolvent to the hydrolysis reaction with either isoenzyme.
Interestingly, only PLE isoenzymes 3 and 5 showed improvement in enantioselectivity
upon the addition of the EtOH to the reaction. The enantioselectivity of the hydrolysis
reaction with PLE 3 was improved from 30% ee to 48% ee upon the addition of 2%
EtOH while the enantioselectivity of PLE 5 was improved nearly the same magnitude
from 41% ee to 57% ee (Figure 20).
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Figure 20. Results of PLE hydrolysis assay of 10 and either 0% or 2% EtOH. Grey bars
represent the % ee obtained using 0% EtOH. Black bars represent the % ee obtained
using 2% EtOH. All isoenzymes produced the (R)-enantiomer predominantly.
PLE hydrolysis assay of substrates 12a-c
The hydrolysis of substrates 12a-c was next performed. However, the half-ester
(19a-c) were not resolved by chiral HPLC. The acid-ester (17a-c) was reacted with
benzyl bromide to provide the ethyl-benzyl mixed diester (18a-c). The % ee was
measured using chiral HPLC (Scheme 20).
It was thought that the increase in the equilibrium constants would be an
indication of a larger change in enantioselectivity when EtOH was added to the PLE
hydrolysis reaction. However, this trend was not observed. In the hydrolysis of 12a with
crude PLE, the product was produced in the racemic form (Scheme 20). Upon addition
of 2% EtOH cosolvent, the enantioselectivity increased to 6% ee. While this is a slight
increase in enantioselectivity, it does not correlate to the large increase observed in the
equilibrium constant.

46

Scheme 20. PLE hydrolysis of diesters 12a-c to give half-esters 17a-c. The half-ester
products (17a-c) were then protected with a benzyl group to give 18a-c.
The PLE hydrolysis reaction of 12a was explored with the isoenzymes.
Interestingly, all the isoenzymes provided the same enantiomer as the predominant
product in the hydrolysis of 14a. The stereochemistry has not yet been determined for
this molecule. However, we believe that the (R) enantiomer is the predominant
enantiomer. Increases in the enantioselectivity were expected when 2% EtOH was added
to the reaction because of the “large” equilibrium constant that was calculated. However,
the enantioselectivity decreased slightly when EtOH was added to the hydrolysis
reactions with PLE 2, PLE 3, and PLE 6. Substrate 14a was not a substrate for PLE 1 as
only the starting material was recovered from the reaction. The highest enantioselectivity
of 40% ee was obtained upon hydrolysis of 14a with PLE 5 and 2% EtOH cosolvent
(Figure 21).
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Figure 21. Results of PLE hydrolysis assay of 12a. Grey bars represent % ee obtained
from hydrolysis with 0% EtOH. Black bars represent % ee obtained from hydrolysis
with 2% EtOH. Stereochemistry has not yet been determined for this molecule.
Interestingly, very different results were observed for the hydrolysis of 12b and
12c compared to the hydrolysis of 12a. Different selectivities were observed for the
various isoenzymes upon hydrolysis of 12b. PLE isoenzymes 5 and 6 provided the
highest enantioselectivity of approximately 45% ee (S) enantiomer. The chirality of halfester 17b was determined by conversion of 17b obtained from hydrolysis with PLE
isoenzyme 5 to the amino acid by a Curtius rearrangement.36 Polarimetry was performed
in 1 N HCl to determine the absolute stereochemistry of the amino acid. The levorotatory
direction of rotation was consistent with that of (R) amino acid.97 This result indicates
that the major enantiomer of 17b must be of the (S) configuration.
Hydrolysis of 12b with PLE 4 provided the (R) enantiomer in 40% ee.
Hydrolysis of 12b with PLE 1 resulted in recovery of starting material, and 17b was not
obtained. However, the enantioselectivity was not improved upon addition of 2% EtOH
to any of the reactions (Figure 22).

48

Figure 22. Results of PLE hydrolysis assay of 12b. Grey bars represent % ee obtained
from hydrolysis with 0% EtOH. Black bars represent % ee obtained from hydrolysis
with 2% EtOH. Positive % ee represents (S)-enantiomer. Negative % ee represents (R)enantiomer.
Lastly, the hydrolysis of 12c was performed. Diester 12c was hydrolyzed with
the various isoenzymes and either 0% EtOH or 2% EtOH to obtain the half-ester 17c.
Upon hydrolysis with PLE 1 or PLE 2, only starting material was recovered from both of
these reactions indicating 12c was not a suitable substrate for these isoenzymes. Crude
PLE, PLE 5, and PLE 6 all produced the same enantiomer in moderate
enantioselectivities. The stereochemistry of 17c has not yet been determined; however,
because of its structural similarity to 17b, it is believed that this is the (S) enantiomer.
Interestingly, addition of 2% EtOH to any of the hydrolysis reactions caused a
decrease in the enantioselectivity. The highest enantioselectivity was observed with PLE
6 (55% ee) and was decreased to 40% ee upon the addition of 2% EtOH. PLE 3 and PLE
4 both produced the (R) enantiomer in approximately 40% ee without cosolvent. Upon
addition of 2% EtOH cosolvent, the enantioselectivity decreased in both reactions (Figure
23).
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Figure 23. Results of PLE hydrolysis assay of 12c. Grey bars represent % ee obtained
from hydrolysis with 0% EtOH. Black bars represent % ee obtained from hydrolysis
with 2% EtOH. Stereochemistry has not yet been determined for this molecule; however,
it is likely that this molecule has the same stereochemistry as 12b.
Although very interesting, a clear explanation for these results has not yet been
developed. It is interesting that the addition of ethanol to the hydrolysis reaction of 12c
caused a decrease in enantioselectivity. One possible explanation is proposed using the
Jones Active Site Model (Figure 24). In hydrolysis without cosolvent, it is possible that
the nitrogen atom in the pyridine ring can form a hydrogen bond with a polar amino acid
available in the HL pocket. When the hydrogen bond is formed between the side chain
and the enzyme pocket, the substrate is locked into that position. However, when
ethanol is added to the reaction, the hydrogen bond between the substrate and enzyme is
disrupted. Because the substrate is no longer anchored to the hydrophobic large pocket, it
can freely orient itself between the hydrophobic large or hydrophobic small pocket,
causing a decrease in enantioselectivity (Figure 24). Preliminary molecular modeling
experiments performed by collaborators at the University of Greifswald support this
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hypothesis. Experiments that could be performed to evaluate this hypothesis are
discussed in Chapter V.

Figure 24. Possible explanation of decrease in the % ee when EtOH is added to the
hydrolysis reaction of 12c. The model on the left represents no EtOH added to the
hydrolysis reaction. In this situation, the nitrogen is able to form a hydrogen bond with
an amino acid residue in the pocket. When EtOH is added, as shown on the right, the
original hydrogen bond is disrupted by EtOH.
Transesterification study
A transesterification study was performed to gain a better understanding of how
the cosolvents were influence the PLE hydrolysis reaction. In this study, substrate 1 was
hydrolyzed in the presence of deuterated ethanol (Scheme 21). If the ethanol is able to
get into the active site, we would expect to see product that has the deuterium label
incorporated.

Scheme 21. Hydrolysis of 1 with PLE using d5-EtOD.
A control experiment was first performed in which 1 was placed in a reaction tube
with a solution containing 2% ethanol-d6/buffer. Enzyme was not added to the reaction
tube. After several days, an aliquot of the reaction mixture was taken and analyzed by

51
mass spectrometry. The mass detected corresponded only to the starting material (1),
indicating that hydrolysis does not occur to any appreciable extent in the absence of the
PLE enzyme (Figure 25). Also, trans-esterified product was not detected in this sample,
indicating that transesterification does not occur in the absence of the enzyme.
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Figure 25. Mass spectrum for the control reaction containing d5-EtOD. Enzyme was not
present in this reaction. The sodium adduct of the diester was predominantly present
(356 m/z). The identity of the 311 m/z ion is unknown.
Next, 1 was placed in a reaction tube along with 2% d6-ethanol/buffer and either
crude PLE or an isoenzyme. After several days, an aliquot of the reaction mixture was
taken and analyzed by mass spectrometry. In all hydrolysis reactions, with the exception
of PLE 1 and PLE 2, masses corresponding to the sodium adduct of the half-ester (328
m/z) (4) as well as the sodium adduct of the deuterated half ester (333 m/z) (d5-4) were
detected (Figure 26). Interestingly, the mass of the D5/H5 diester (361 m/z) was not
detected. This result indicates that hydrolysis does occur in the presence of the enzyme,
and the enzyme is able to incorporate the deuterium label into the molecule.
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Figure 26. Mass spectrum obtained from hydrolysis of 1 with PLE 6 and 2% d5-EtOD.
The mass of 328 m/z corresponds to the half-ester (4). The mass of 333 m/z corresponds
to the deuterated half-ester (d5-4). The mass of 355 m/z is an impurity arising from the
PLE enzyme.
The results indicate that the cosolvent is able to enter into the active site of the
enzyme. Once in the active site of the enzyme, it is possible that the cosolvent can
interact with both the substrate and enzyme causing changes in the enantioselective
outcome of the reaction.
Altering the hydrogen bonding capability of solvent
As discussed above, a series of substrates was synthesized to determine the effect
of hydrogen bonding on the PLE hydrolysis reaction. Alternatively, another approach to
explore the hydrogen bond interaction between the substrate and solvent is to alter the
hydrogen bond formation ability of the substrate. Trifluoroethanol was chosen due to its
structural similarity to ethanol. TFE contains three fluorine atoms. Trifluoroethanol is
more acidic compared to EtOH and thus exhibits a larger hydrogen bond donation
ability.98,99
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The hydrolysis of 1 was performed in the presence of 2% TFE and the
isoenzymes of PLE (Scheme 22). The cosolvent study was conducted in a similar
manner as the cosolvent study with EtOH.

Scheme 22. Hydrolysis of 1 in the presence of 2% TFE.
Interestingly, TFE has a similar overall effect on enantioselectivity as does EtOH.
However, the magnitude of enantioselectivity was altered in the presence of TFE. In
most of the hydrolysis reactions with TFE, the % ee was lower than the % ee obtained
from hydrolysis without cosolvent. For example, hydrolysis of 1 with PLE 1 provided
the (R) enantiomer in 87% ee, whereas addition of 2% TFE caused a decrease in
enantioselectivity (67% ee, (R) enantiomer). Addition of 2% TFE to the hydrolysis of 1
with PLE isoenzymes 3-6 did not cause a complete solvent induced inversion of
enantioselectivity like 2% EtOH cosolvent. Hydrolysis of 1 with crude PLE and 2% TFE
was the only reaction that provided an improvement in enantioselectivity. In the absence
of cosolvent, hydrolysis of 1 with crude PLE produced the (R) enantiomer in 23% ee.
Hydrolysis of 1 with crude PLE and 2% TFE provided the (R) enantiomer in 38% ee.
However, the improvement in enantioselectivity is not as dramatic as the improvement
observed for addition of 2% EtOH (78% ee, (R) enantiomer) (Figure 27).
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Figure 27. Results of PLE hydrolysis assay of 1 with tri-fluoroethanol (TFE). Purple
bars represent % ee obtained from hydrolysis with 2% TFE. Results from hydrolysis
with 0% EtOH (black bars) and 2% EtOH (grey bars) are plotted for comparison.
Positive % ee represents (R)-enantiomer. Negative % ee represents (S)-enantiomer.
The hydrolysis of 3 was conducted with crude PLE, the PLE isoenzymes and 2%
TFE cosolvent (Scheme 23). Again, TFE has a similar overall effect of enantioselectivity
as EtOH. However, the magnitude of enantioselectivity was altered in the presence of
TFE. All reactions provided the (R) enantiomer as the predominant product. However,
the addition of TFE to the hydrolysis reactions did not provide any clear trend.

Scheme 23. Hydrolysis of 3 in the presence of 2% TFE.
Hydrolysis of 3 with either crude PLE or PLE 6 and 2% TFE provided
improvements in enantioselectivity compared to hydrolysis without cosolvent.
Hydrolysis of 3 with PLE 6 and 2% TFE cosolvent provided higher enantioselectivity
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(79% ee) than the reaction with 2% EtOH (74% ee). However, in several reactions, there
was a deleterious effect on the enantioselectivity of the reaction when TFE was added.
Hydrolysis of 3 with PLE 3 and PLE 4 showed approximately a 10% decrease in
enantioselectivity compared to the reaction with 0% cosolvent. Hydrolysis of 3 with PLE
1 and PLE 2 provided a much greater loss in enantioselectivity. A 40% loss in
enantioselectivity was observed for PLE 1 upon addition of 2% TFE to the reaction, and a
77% loss in enantioselectivity for PLE 2 upon addition of 2% TFE (Figure 28).
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Figure 28. Results of PLE hydrolysis assay of 3 with tri-fluoroethanol (TFE). Purple
bars represent % ee obtained from hydrolysis with 2% TFE. Results from hydrolysis
with 0% EtOH (black bars) and 2% EtOH (grey bars) are plotted for comparison. All
gave the (R)-enantiomer as the predominant product.
Hydrolysis of 5 in the presence of 2% TFE was also performed (Scheme 24).
Again, the trend was similar to that without cosolvent.
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Scheme 24. Hydrolysis of 5 in the presence of 2% TFE.
A slight improvement in enantioselectivity was achieved upon addition of 2%
TFE to the hydrolysis reaction of 5 with either PLE 3 or PLE 4 compared to the reaction
without cosolvent. Addition of 2% TFE to the hydrolysis reaction with PLE 6 caused a
25% decrease in enantioselectivity compared to the reaction without cosolvent.
However, the other reactions provided nearly the same enantioselectivity as observed
with no cosolvent and 2% EtOH added (Figure 29).
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Figure 29. Results of PLE hydrolysis assay of 5 with tri-fluoroethanol (TFE). Purple
bars represent % ee obtained from hydrolysis with 2% TFE. Results from hydrolysis
with 0% EtOH (black bars) and 2% EtOH (grey bars) are plotted for comparison.
Positive % ee represents (R)-enantiomer. Negative % ee represents (S)-enantiomer.
It is interesting that the trifluoroethanol did not greatly improve the
enantioselectivity of the PLE hydrolysis reactions as expected. This may be attributed to
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the acidity of trifluoroethanol (pKa = 12.5) compared to ethanol (pKa = 16).100,101 The
increased acidity may cause a decrease in functionality of the enzyme, leading to a
decrease in enantioselectivity.
Effect of cosolvent on reaction rate
Other than enantioselectivity, the reaction rate and yield can also be affected upon
the addition of organic cosolvent to the reaction.75 A p-nitro phenyl acetate assay was
used to determine how the reaction rate is altered upon the addition of EtOH. In most
cases, there were only minor alterations in the rate when EtOH was added to the reaction.
The greatest enhancement was observed upon addition of 2% EtOH to the hydrolysis
reaction with PLE 6. However, the rate of the hydrolysis with PLE 6 was decreased upon
further addition of EtOH. Overall, ethanol did not appear to greatly influence the
reaction rate of the hydrolysis of pNPA (Figure 30).
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Figure 30. Effect of EtOH cosolvent on relative reaction rate. Reaction rates are relative
to the rates determined without EtOH.
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Conclusions
The above chapter details the results of the PLE hydrolysis reactions with several
substrates. This dissertation details one of the first accounts of evaluating the addition of
cosolvents to hydrolysis reactions with the individual isoenzymes of PLE. Each of the
individual isoenzymes provided different enantioselectivities. The enantioselectivity was
dependent on substrate as well as cosolvent. It was demonstrated that the addition of
organic cosolvent medium can be added to the PLE hydrolysis reaction to alter the
enantioselective outcome of the reaction. Several solvents were evaluated; however,
ethanol provided the most dramatic improvements in enantioselectivity. The ability of
ethanol to improve the enantioselectivity of the hydrolysis reaction was also dependent
on the substrate. The enantioselectivity of the hydrolysis reaction of substrates such as 1
and 3, was influenced more when EtOH was added. This improvement in
enantioselectivity was hypothesized to be due to the presence of atoms capable of
forming hydrogen bonds in the side chain. In comparison, substrates with more nonpolar side chains, such as 5, were not influenced as much by the addition of EtOH.
Equilibrium constants were calculated for the various substrates with ethanol.
Substrates that have atoms capable of forming hydrogen bonds had the largest
equilibrium constants. Initially, it was thought that the hydrolysis reactions of the
substrates with the largest equilibrium constants would be most influenced by the
addition of EtOH to the reaction. However, this correlation only existed for certain
substrates. For example, the substrates with the pyridine ring had the largest equilibrium
constants. However, the enantioselectivity of the crude PLE hydrolysis reaction was only
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improved minimally upon addition of 2% EtOH. Addition of cosolvent does not
automatically indicate an improvement of enantioselectivity.
The hydrogen bonding hypothesis holds true for substrate 1. It is believed that a
substrate must be of a certain size in addition to containing atoms capable of forming
hydrogen bonds. For example, the phthalimide group is larger than other R groups of the
series. In the absence of EtOH cosolvent, the phthalimide can fit into the hydrophobic
large or hydrophobic small pocket, causing the enantioselectivity of the reaction to be
low.

When EtOH is added to the reaction, there are several explanations for
why the enantioselectivity is increased. The first explanation is that the substrate and
ethanol form a complex. The complex is then too large to fit in the hydrophobic small
pocket and only fits in the hydrophobic large pocket, causing an improvement in
enantioselectivity. It is also possible that the EtOH can interact with polar residues in the
hydrophobic large or hydrophobic small pocket and cause a shielding effect. Chapter V
will discuss other factors that must be taken into account when trying to predict the
enantioselectivity of the PLE hydrolysis reaction.
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Experimental
General: All reagents were used as received from commercial sources. Solvents,
such as THF, CH2Cl2, Et3N, and DMF, were dried by passage through a column of
activated alumina. Column chromatography was performed on P-60 silica gel. NMR
spectra were obtained using a 400 MHz Bruker NMR or 300 MHz Varian spectrometer.
Low resolution mass spectrometry was performed on a ThermoFisher LXQ ESI-Ion trap
mass spectrometer. High resolution mass spectrometry was performed on an Apex FTMS at Old Dominion University.
Melting points were determined in open capillary tubes and are uncorrected. IR
was conducted on Thermo Nicolet Nexus 470 FT-IR instrument. Crude PLE is
commercially available from Sigma Aldrich. PLE isoenzymes were obtained from
Enzymicals AG and used without further preparation.
Enzyme assays (General Procedure):
Approximately 1.5 mg of the substrate under study was placed in a 2.0 mL
Eppendorf® tube with 1.0 mL of the appropriate reaction medium (buffer/cosolvent
mixtures). Stock solutions of the various PLE isoenzymes and crude PLE were prepared
in 3 M (NH4)2SO4. An aliquot of the PLE solution under study was added to each tube
(0.5 units total). The six isoenzymes each have different activities, so all reactions were
normalized to contain 0.5 units of the appropriate enzyme. The samples were placed in
an Eppendorf® Thermomixer at 25 ˚C and 1400 RPM mixing rate. The samples were
mixed continuously for two to five days.
General ESI-MS procedure

61
This method was used as previously reported utilizing isotope labeled probe
molecules of known enantiomeric excess.15 The synthesis of these probes is outlined
below. This method was utilized for non-nucleophilic cosolvents, including DMF, THF,
MeCN, acetone, i-PrOH, and t-BuOH. A 200 µL aliquot of the resulting hydrolysis
reaction media was taken and placed in a glass autosampler vial and diluted with 200 µL
of 1% (v/v) acetic acid in MeOH. The autosampler was programmed to inject 1 µL onto
either a Hypersil Gold RP HPLC column (50 x 2.1 mm, ThermoFisher), or Rigel C18 RP
HPLC column (4.6 x 250 mm). The mobile phase was 70:30 (v/v) MeOH/H2O at flow
rates of 100 µL/min for the Hypersil Gold RP HPLC column or 750 µL /min, for the
Rigel C18 RP HPLC column. The samples were desalted by diverting the initial 2 min.
of flow to waste. The data was collected in Selected Ion Monitoring (SIM) mode, and the
observed enantiomeric excess was calculated by comparing the intensities of the peaks.
The observed % ee was divided by the starting % ee of the probe to obtain the corrected
% ee for the reaction.
General APCI-MS procedure
This method was utilized in the determination of enantiomeric excess when EtOH
was used as the cosolvent for substrates 1, 3, and 5. A 400 µL aliquot of the resulting
hydrolysis reaction media was taken and filtered through a syringe filter to remove
enzyme. After filtration, the aliquot was acidified with 200 µL conc. H2SO4. The
solution was extracted with 400 µL CH2Cl2. The CH2Cl2 layer was placed into a glass
autosampler vial and dried down under a stream of N2. The samples were then
reconstituted in 350 µL of 4% i-PrOH/96% (v/v) hexane. The autosampler was
programmed to inject 25 µL onto an analytical Chiralcel OJ-H Chiral Column. The
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mobile phase was 4% i-PrOH/96% (v/v) hexane at a flow rate of 1.0 mL/min. The data
was collected in full scan mode. The enantiomeric excess was calculated by creating the
reconstructed ion chromatograms (RIC) for ions of interest and comparing the peak areas
of the two enantiomers. All ions were detected as the [M+H]+ ions.
Enzyme assays for hydrolysis of 8.
The enzyme assays were performed the same as the general procedure detailed
above. After mixing for four days, the solution was acidified with 100 µL H2SO4 and
extracted with CH2Cl2. The CH2Cl2 was removed under a stream of N2 leaving a clear
film on the inside of the tube. Approximately 1 mL MeCN was added to each
Eppendorf® tube, along with 3 µL (0.024 mmol) benzyl bromide and 3.3 mg (0.024
mmol) K2CO3. The tubes were placed in an Eppendorf® Thermomixer at 25 ˚C and 1400
RPM mixing rate for two days. After this time, the MeCN was removed to leave a white
solid. An aliquot of hexanes was added to each Eppendorf tube and mixed. The hexane
was filtered through glass wool to remove any K2CO3. The hexane was then dried under
a stream of nitrogen. The sample was reconstituted in 1.0 mL MeCN. A 5 mg portion of
SiliaMetS® Thiol resin from Silicycle and 7 µL Et3N was added to each Eppendorf tube
to remove Excess benzyl bromide. The Eppendorf tubes were placed in an Eppendorf®
Thermomixer at 35 ˚C and 1400 RPM mixing rate overnight. After the solution mixed
overnight, it was filtered through a glass wool pipette to remove the resin. The MeCN
was dried under a stream of nitrogen to give the desired product. The products were
reconstituted in 10% i-PrOH/90% (v/v) hexane and analyzed by APCI-MS. The
autosampler was programmed to inject 25 µL onto an analytical Chiralcel OJ-H Chiral
Column. The mobile phase was 10% i-PrOH/90% (v/v) hexane at a flow rate of 1.0
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mL/min. The enantiomeric excess was calculated by creating the reconstructed ion
chromatograms (RIC) for the m/z of interest and comparing the peak areas of the two
enantiomers.
Enzyme assays for pyridine diester analogues (12a-c)
The enzyme assays for substrates 12a-c were performed in a similar manner to the
enzyme assay of 8. After mixing for two days, the buffer solution was removed by
evaporation under reduced pressure to produce a white material. An aliquot of CHCl3
was added to the flask, mixed, and the CHCl3 was decanted, filtered, and dried down to
leave the acid-ester. Approximately 1 mL MeCN was added to each Eppendorf® tube,
along with 5 µL (0.042 mmol) benzyl bromide and 5.8 mg (0.042 mmol) K2CO3. The
tubes were placed in an Eppendorf® Thermomixer at 25 ˚C and 1400 RPM mixing rate
for two days. After this time, the MeCN was removed to leave a white solid. An aliquot
of hexanes was used to remove the product. The hexane was then dried under a stream of
nitrogen. The sample was reconstituted in 1.0 mL MeCN. A 5 mg portion of
SiliaMetS® Thiol resin from Silicycle and 7 µL Et3N was added to each Eppendorf tube
to remove excess benzyl bromide. The Eppendorf tubes were placed in an Eppendorf®
Thermomixer at 35 ˚C and 1400 RPM mixing rate overnight. After the solution mixed
overnight, it was filtered through a glass wool pipette to remove the resin. The MeCN
was dried under a stream of nitrogen to give the desired product. The products (18a-c)
were reconstituted in 10% i-PrOH/90% (v/v) hexane and analyzed by APCI-MS. The
autosampler was programmed to inject 25 µL onto an analytical Chiralcel OJ-H Chiral
Column. The mobile phase was 10% i-PrOH/90% (v/v) hexane at a flow rate of 1.0
mL/min. The enantiomeric excess was calculated by creating the reconstructed ion
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chromatograms (RIC) for the m/z of interest and comparing the peak areas of the two
enantiomers.
NMR titration general procedure
A solution of substrate under consideration (0.03 M) was prepared in dry CDCl3
with added excess TMS. A solution of EtOH (6 M) was prepared in dry CDCl3 with
added excess TMS. A 500 µL aliquot of substrate solution was placed in an NMR tube.
A 13C-NMR spectrum was obtained using 256 scans. A 50 µL aliquot of the EtOH
solution was added to the NMR tube, and another 13C-NMR spectrum was obtained. This
procedure was repeated until 500 µL of the EtOH solution had been added. After each
EtOH addition, the concentrations of EtOH and substrate in solution were calculated.
Using the concentrations, the ratio of EtOH to substrate was calculated for each addition.
After all additions were complete, the final EtOH to substrate ratio was 200:1.
The spectra were referenced to TMS, and the chemical shifts for the desired
signals were recorded. All 13C-NMR were obtained on a Bruker 400 MHz instrument.
Equilibrium constants were determined by using the program provided by Hirose.90
Diethyl 2-methyl-2-((1,3-dioxoisoindolin-2-yl)methyl)malonate (1):
Synthesized according to a literature procedure. Characterization data matches
that of previously reported material.44
probe-1
Prepared according to a literature procedure. Characterization data matches that
of previously reported material.44 A 50 mL round bottom flask was charged with 2
(0.520g, 1.7 mmol, 91%ee), 25 mL of anhydrous CH2Cl2, and a stir bar. Thionyl chloride
(1.84 mL, 1.7 mmol) was added to the flask, and the solution was heated to reflux solvent
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overnight under a nitrogen atmosphere. The solution was concentrated under reduced
pressure. A solution containing 261 μL anhydrous Et3N in 1 mL ethanol-d6 was added
dropwise to the acid chloride under a dry N2 atmosphere. The solution was stirred
overnight at room temperature under a dry N2 atmosphere. The resulting mixture was
diluted with 25 mL ether and washed three times each with 10% (v/v) HCl and 1.0 M
NaOH. The organic layer was dried over MgSO4 and concentrated to give probe-1 as a
white solid (0.35 g, 1.04 mmol, 62% yield). Rf = 0.62 (12.5:87.5 EtOAc:Hexanes). MP =
100.5 °C. IR (cm-1): 1718. 1H-NMR (400 MHz, CDCl3): 7.84 (2H, m), 7.72 (2H, m), 4.25
(q, J =7.2 Hz, 2H), 1.59 (s, 2H), 1.41 (s, 3H), 1.30 (t, J = 7.1 Hz, 3H); 13C-NMR (100
MHz, CDCl3): 170.6, 168.2, 134.1, 131.8, 123.5, 61.9, 58.6, 42.0, 18.3, 13.9. HRMS:
[C17H14D5NO6Na+] calculated = 361.1418, found = 361.1414.
2-(ethoxycarbonyl)-2-((1,3-dioxoisoindolin-2-yl)methyl)propanoic acid (2):
Synthesized according to a literature procedure. Characterization data matches
that of previously reported material.44
Diethyl 2-(benzyloxy(methyl)-2-methyl malonate (3):
Synthesized according to a literature procedure. Characterization data matches
that of previously reported material.12
Probe-3:
Synthesized according to a literature procedure. Characterization data matches
that of previously reported material.15
(R)-2-(4-(benzyloxymethyl)-3-ethoxy-2-methyl-3-oxopropanoic acid (4):
4 was synthesized according to a literature procedure. Characterization data
matches that of previously reported material.12
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Diethyl 2-benzyl-2-methylmalonate (5):

5 was synthesized according to a literature procedure. Characterization data
matches that of previously reported material.36
2-(ethoxycarbonyl)-2-benzylpropanoic acid (6):
6 was synthesized according to a literature procedure. Characterization data
matches that of previously reported material.36
Diethyl 2-methyl-2-((1,3-dithioxoisoindolin-2-yl)methyl)malonate (7):
A portion of 1 (1.0 g, 3 mmol) was placed into a sealed tube along with 50 mL
dry toluene. A stir bar was added to the tube. A portion of Lawesson’s reagent (1.2 g, 2
equiv.) was added to the tube. The tube was sealed and placed into an oil bath at 110˚C.
The solution stirred at this temperature for four days. The solution was cooled to room
temperature, and the toluene removed by rotary evaporation to produce a dark brown oil.
The material was purified by column chromatography using 30:70 Et2O:Hexanes. The
product was isolated as a dark red/brown solid material (0.65g, 1.8 mmol, 60% yield). Rf
= 0.3 (25:75 Et2O:Hexanes). MP = 60-61 ˚C. IR (cm-1): 2979, 1724. 1H-NMR (400 MHz,
CDCl3): δ 7.90 – 7.79 (m, 2H), 7.71 – 7.64 (m, 2H), 5.23 (s, 2H), 4.23 (4H, m), 1.37 (s,
3H), 1.28 (6H, t, J = 7.1 Hz).; 13C-NMR (100 MHz, CDCl3): δ 198.50, 170.94, 134.75,
133.30, 123.57, 61.97, 53.94, 45.89, 18.46, 13.92. HRMS: [C17H19NO4S2Na+] calculated
= 388.0647, found = 388.0645.
Diethyl 2-methyl-2-((1-oxo-3-thioxoisoindolin-2-yl)methyl)malonate (8):
A 100 mL round bottom flask was charged with 1 (1.0 g, 3 mmol) and 50 mL dry
toluene. A stir bar was added to the flask, and a reflux condenser equipped with a
nitrogen inlet was attached to the round bottom flask. A portion of Lawesson’s reagent
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(0.6 g, 3 mmol) was added to the flask. The flask was placed in an oil bath at 110˚C.
The solution stirred at this temperature overnight. After stirring, the solution was cooled
to room temperature, and the toluene removed by rotary evaporation to produce a dark
brown oil. The material was purified using column chromatography and 25:75
EtOAc:Hexanes. The product was isolated and concentrated down to produce the
product (0.41 g, 1.2 mmol, 39% yield) as an orange solid material. Rf = 0.19 (25:75
Et2O:Hexanes). MP = 99-100 ˚C. IR (cm-1): 2927, 1745, 1719. 1H-NMR (400 MHz,
CDCl3): δ 8.01 – 7.88 (m, 1H), 7.79 – 7.74 (m, 1H), 7.70 (dd, J = 5.6, 3.1 Hz, 2H), 4.72
(s, 2H), 4.33 – 4.14 (m, 4H), 1.40 (s, 3H), 1.30 (t, J = 7.1 Hz, 6H). 13C-NMR (100 MHz,
CDCl3): δ 197.88, 170.69, 169.89, 137.21, 134.24, 133.36, 126.83, 124.27, 122.92, 61.89,
53.92, 44.20, 18.48, 13.93. HRMS: [C17H19NO5SNa+]: calculated = 372.0876;
found = 372.0873.
Benzyl chloromethyl sulfide (9):
Alkylating agent 9 was prepared according to a modified literature procedure.95
The literature procedure was modified to use THF as the solvent rather than DMF.
Additionally, the reaction was performed under a nitrogen atmosphere instead of an
argon atmosphere. Characterization data matched that of previously reported material.95
Diethyl 2-(benzylthiomethyl)-2-methyl malonate (10):
Substrate 10 was synthesized according to a modified literature procedure.95 A
three neck 500 mL round bottom flask equipped with a reflux condenser and nitrogen
inlet was charged with a stir bar, 200 mL dry THF, and a portion of NaH (2.55 g, 63.7
mmol, 60% dispersion in mineral oil). The THF solution was cooled to 0 ˚C. A solution
of diethyl methyl malonate (9.2 g, 52.6 mmol) in 50 mL dry THF was added dropwise to
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the solution with stirring. The resulting solution was stirred for 1 hr. A solution of
benzyl chloromethyl sulfide (10 g, 57.9 mmol) in 50 mL THF was added dropwise to the
solution. The reaction was then heated to solvent reflux overnight. The solution was
cooled and diluted with 300 mL Et2O. The organic layer was washed with brine and
dried over MgSO4, and the solvent removed by rotary evaporation to produce a dark red
oil. The red oil was purified using column chromatography (40:60 Et2O:Hexanes) to
produce the product as a light yellow oil (12 g, 38.7 mmol, 73%). Characterization data
matched that of previously reported material.95
General synthesis of 2, 3, and 4-chloromethylpyridine HCl (11a-c):
One equivalent of either 2, 3, or 4-pyridinemethanol with 250 mL dry THF was
placed in a 500 mL round bottom flask. The flask was fitted with a star bar, nitrogen
inlet and placed in an ice bath. A portion of SOCl2 (1.1 equivalent) was added dropwise
to the flask. The solution stirred in the ice bath for 45 min. After stirring, the pH was
adjusted to 8 with saturated NaHCO3. The organic layer was extracted with CH2Cl2,
dried over MgSO4, filtered, and concentrated under reduced pressure. The material was
passed through a silica plug and immediately used in the alkylation reaction. Due to the
reactive nature of the material, characterization data was not obtained.
2-chloromethyl pyridine (11a):
11a was synthesized by using the general procedure for synthesis of 11a-c with
10 mL of 2-pyridinemethanol and 8.3 mL of SOCl2. Approximate yield: 5 mL, 51.8
mmol, 56% yield.
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3-chloromethyl pyridine (11b):
11b was synthesized by using the general procedure for synthesis of 11a-c with
10 g of 3-pyridinemethanol and 9 mL of SOCl2. Approximate yield: 6.1 g, 47 mmol,
51% yield.
4-chloromethyl pyridine (11c):
11c was synthesized by using the general procedure for synthesis of 11a-c with 10
g of 4-pyridinemethanol and 10 mL of SOCl2. Approximate yield: 6.2 g, 48 mmol, 53%
yield.
General synthesis of pyridine analogues (12a-c):
A three neck 500 mL round bottom flask equipped with a reflux condenser and
nitrogen inlet was charged with a stirbar, dry THF, and NaH (60% dispersion in mineral
oil). The THF solution was cooled to 0 ˚C. A solution of diethyl methyl malonate in dry
THF was added dropwise to the solution with stirring. The resulting solution was stirred
for one hour. During this time, the chloromethyl pyridine was prepared as described. A
solution of the chloromethyl pyridine in 50 mL THF was added dropwise to the reaction
solution. The reaction was then heated to solvent reflux overnight. The flask was cooled
to room temperature, and the THF was removed under reduced pressure. Distilled water
was added to the material. The aqueous layer was acidified with concentrated H2SO4.
The aqueous layer was washed with Et2O (3 x 100 mL) to remove any unreacted diethyl
methyl malonate. The aqueous layer was then neutralized with NaOH. The aqueous
layer was extracted with Et2O (3 x 100 mL). The organic layer was dried over MgSO4,
filtered, and concentrated under reduced pressure to give the product. Note: In all three
syntheses, some of the product underwent decarboxylation. The decarboxylated material
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was not separated from the desired product at this stage. However, separation and
purification was possible after the PLE hydrolysis reaction. During the synthesis of each
diester, it is believed that one of the esters underwent hydrolysis followed by
decarboxylation. Various chromatographic conditions were explored to separate the
mixture of the diester and impurity. However, based on mass spectrometry and NMR
data, the impurity was produced in very small quantities. Because the impurity was
produced in such low quantities, NMR titrations and PLE hydrolysis assays were
performed using the mixture.
Diethyl 2-methyl-2-pyridin-2-yl)methyl malonate (12a):
12a was synthesized according to the general procedure described for the general
pyridine analogues, using diethyl methyl malonate (9.7 mL, 57 mmol), NaH dispersion
(2.5 g, 62.7 mmol), and 2-chloromethyl pyridine (5 mL, 51.8 mmol). The product was
produced as a golden yellow liquid (7.14 g, 26.9 mmol, 52%). Rf = 0.49 (15:85
MeOH:CH2Cl2). IR (cm-1) 2982.02, 1726.72. 1H-NMR (CDCl3, 400 MHz): δ 8.49 (m,
1H), 7.56 (m, 1H), 7.18 – 7.02 (m, 2H), 4.28 – 4.11 (m, 4H), 3.41 (d, J = 2.1 Hz, 2H),
1.40 (d, J = 2.0 Hz, 3H), 1.32 – 1.12 (m, 6H). δ 13C-NMR (CDCl3, 100 MHz): δ 171.93,
157.22, 149.10, 136.01, 124.32, 121.61, 61.33, 54.15, 43.12, 19.87, 14.02. HRMS:
[C14H19NO4Na+] calculated = 288.1206, found = 288.1206.
Diethyl 2-methyl-2-pyridin-3-yl)methyl malonate (12b):
12b was synthesized according to the general procedure described for the general
pyridine analogues, using diethyl methyl malonate (8.9 mL, 52.1 mmol), NaH dispersion
(2.3 g, 57.2 mmol), and the 3-chloromethyl pyridine (6.1 g, 47 mmol) to provide the
product as a golden liquid (4.6 g, 17.4 mmol, 37% yield). Rf = 0.47 (15:85
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MeOH:CH2Cl2). IR (cm-1) 2982, 1727. 1H-NMR (400 MHz, CDCl3) δ 8.48 (m, 1H),
8.40 (m, 1H), 7.56 – 7.41 (m, 1H), 7.20 (m, 1H), 4.19 (m, 4H), 3.21 (s, 2H), 1.36 (s, 3H),
1.25 (td, J = 7.1, 1.1 Hz, 6H). 13C-NMR (100 MHz, CDCl3) δ 171.51, 151.36, 148.40,
137.57, 131.91, 123.08, 61.56, 54.64, 38.41, 19.83, 14.02. HRMS: [C14H19NO4Na+]
calculated = 288.1206, found = 288.1206.
Diethyl 2-methyl-2-pyridin-4-yl)methyl malonate (12c):
12c was synthesized according to the general procedure described for the general
pyridine analogues, using diethyl methyl malonate (9.1 mL, 53 mmol), NaH dispersion
(2.33 g, 58.3 mmol), and the 4-chloromethyl pyridine (6.2 g, 48 mmol) to provide the
product as a golden liquid (6.2 g, 23.5 mmol, 49% yield). Rf = 0.47 (15:85
MeOH:CH2Cl2). IR (cm-1) 2983, 1727. 1H-NMR (400 MHz, CDCl3) δ 8.49 (m, 2H),
7.14 – 7.04 (m, 2H), 4.20 (m, 4H), 3.20 (s, 2H), 1.35 (s, 3H), 1.25 (m, 6H).13C-NMR
(100 MHz, CDCl3) δ 171.38, 149.64, 145.37, 125.48, 61.59, 54.33, 40.49, 19.82, 13.99.
HRMS: [C14H19NO4Na+] calculated = 288.1206, found = 288.1207.
Racemic 2-(ethoxycarbonyl)-3-(benzylthio)-2-methylpropanoic acid (15):
A 50 mL round bottom flask was charged with 10 (1.0 g, 3.2 mmol), a stir bar,
and 4 mL EtOH. A portion of NaOH (0.13 g, 3.2 mmol) was added, and the solution was
stirred overnight at room temperature. The EtOH was removed under reduced pressure to
leave the aqueous layer. A 5 mL portion of distilled water was added to the solution.
The aqueous layer was extracted with Et2O (3 x 10 mL). The pH of the solution was
adjusted to pH 3 with 50% HCl. The aqueous layer was extracted with Et2O (3 x 10 mL).
The organic layer was dried over MgSO4, filtered, and solvent removed by rotary
evaporation to provide the product as a viscous yellow liquid (0.53 g, 1.9 mmol, 59%).
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Rf = 0.24 (25:75 EtOAc:Hexanes). IR (cm-1): 2982, 1706. 1H-NMR (400 MHz, CDCl3)
δ 10.85 (s, 1H), 7.38 – 7.10 (m, 5H), 4.19 (qd, J = 7.1, 1.6 Hz, 2H), 3.72 (s, 2H), 3.11 –
2.81 (s, 2H), 1.58 – 1.44 (m, 3H), 1.24 (t, J = 7.1 Hz, 3H). 13C-NMR (100 MHz, CDCl3)
δ 176.84, 170.90, 137.84, 128.92, 128.50, 127.15, 61.99, 54.96, 37.95, 36.91, 19.91,
13.92. HRMS: [C14H18O4SNa+] calculated = 305.0818, found = 305.0816.
Racemic 1-benzyl 3-ethyl 2-((benzylthio)methyl)-2-methylmalonate (16):
A portion of 15 (0.052 g, 0.18 mmol) was placed in an Eppendorf tube with 1.5
mL MeCN. An aliquot of benzyl bromide (22 µL, 0.18 mmol) was added along with a
portion of K2CO3 (0.025 g, 0.18 mmol). The Eppendorf tube was placed in the
Thermomixer® overnight at 25˚C and 1400 RPM mixing speed. After mixing, the
solution was filtered, and the solvent removed under a stream of nitrogen.
Approximately 1 mL of a 1:1 EtOH:THF solution was added to the tube along with 14µL
Et3N and SiliaMetS® Thiol resin. The solution was mixed overnight at 35˚C and 1400
RPM mixing speed. The solution was filtered, and solvent removed under a stream of
nitrogen to produce the pure product (0.05 g, 0.133 mmol, 74%). Rf = 0.43 (25:75
EtOAc:Hexanes). IR (cm-1): 1728. 1H-NMR (400 MHz, CDCl3) δ 7.45 – 7.28 (m, 8H),
7.26 – 7.18 (m, 2H), 5.25 – 5.03 (m, 2H), 4.10 (m, 2H), 3.68 (s, 2H), 3.00 (s, 2H), 1.50
(s, 3H), 1.13 (t, J = 7.1 Hz, 3H).

C-NMR (100 MHz, CDCl3) δ 170.93, 138.00, 135.44,
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128.92, 128.83, 128.50, 128.30, 128.10, 127.11, 67.13, 61.65, 55.00, 37.99, 37.17, 19.81,
13.89. HRMS: [C21H24O4SNa+] calculated =395.1287, found = 395.1286.
General Experimental procedure for preparation of racemic half-esters (17a-c):
A flask was charged with the diester (1.88 mmol for 12a and 12c, and 0.38 mmol
for 12b), 1 equivalent LiOH, 10 mL of 1:1 EtOH:H2O solution, and a stirbar. The
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solution stirred for 24 h. The pH of the solution was adjusted to pH 4 with concentrated
H2SO4. The solution was concentrated down under reduced pressure to produce a solid
grey material. The material was triturated with CHCl3 three times, and then dried to
provide the product.
Racemic 2-(ethoxycarbonyl)-2-((pyridin-2-yl)methyl propanoic acid (17a):
Racemic 17a was prepared according to the general preparation of half ester
procedure, using the diester 12a (0.50 g, 1.88 mmol), LiOH (45 mg, 1.88 mmol), and 10
mL of 1:1 EtOH:H2O solution. The product was produced as a white solid material (0.4
g, 1.7 mmol, 89% yield). Rf = 0.27 (15:85 MeOH:CH2Cl2). MP 115 ˚C. IR (cm-1) 2979,
1712. 1H-NMR (400 MHz, D2O) δ 8.57 (m, 1H), 8.36 (m, 1H), 7.87 – 7.69 (m, 2H), 4.03
(m, 2H), 3.51 – 3.28 (m, 2H), 1.32 (s, 3H), 1.05 (t, J = 7.1 Hz, 3H). 13C-NMR (100 MHz,
D2O) δ 177.33, 174.68, 153.36, 146.10, 140.99, 128.48, 125.23, 62.45, 56.88, 39.39,
20.90, 13.03. HRMS: [C12H15NO4Na+] calculated = 260.0893, found = 260.0892.
Racemic 2-(ethoxycarbonyl)-2-((pyridin-3-yl)methyl propanoic acid (17b):
Racemic 17b was prepared according to the general preparation of half ester
procedure, using 0.10 g (0.38 mmol) of the diester (12b), 9 mg (0.38 mmol) LiOH, 10
mL of 1:1 EtOH:H2O solution to give the product as a grey solid material (0.06g, 0.27
mmol, 72%). Rf = 0.27 (15:85 MeOH:CH2Cl2). MP 130 ˚C. IR (cm-1) 2978, 1713. 1HNMR (CDCl3, 400 MHz): δ 8.49 (d, J = 2.2 Hz, 1H), 8.42 (m, 1H), 7.77 (m, 1H), 7.35
(m, 2H), 4.33 – 4.15 (m, 2H), 3.56 (d, J = 13.6 Hz, 1H), 2.96 (d, J = 13.6 Hz, 1H), 1.44
(s, 3H), 1.30 (t, J = 7.1 Hz, 3H). 13C-NMR (100 MHz, CDCl3) δ 173.47, 172.79, 147.88,
144.93, 140.88, 134.36, 123.74, 61.54, 55.30, 39.19, 20.34, 14.06. HRMS:
[C12H15NO4Na+] calculated = 260.0893, found = 260.0893.
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Racemic 2-(ethoxycarbonyl)-2-((pyridin-4-yl)methyl propanoic acid (17c):
Racemic 17c was prepared according to the general preparation of half ester
procedure, using 0.50 g (1.88 mmol) of the diester (12c), 45 mg (1.88 mmol) LiOH, 10
mL of 1:1 EtOH:H2O solution to give the product as a grey solid material (0.30g, 1.49
mmol, 79%). Rf = 0.27 (15:85 MeOH:CH2Cl2). MP 139 ˚C. IR (cm-1) 2978, 1712. 1HNMR (CDCl3, 400 MHz): δ 8.97 (s, 1H), 8.60 – 8.35 (m, 2H), 7.30 (m, 2H), 4.22 (m,
2H), 3.42 – 3.09 (m, 2H), 1.42 (s, 3H) 1.27 (t, J = 7.1 Hz, 3H). 13C-NMR (CDCl3, 100
MHz): 174.12, 172.45, 149.22, 146.82, 126.47, 61.66, 54.91, 41.12, 20.48, 14.02.
HRMS: [C12H15NO4H+] calculated = 238.1073, found = 238.1074.
General benzylation procedure for racemic 18a-c:
A round bottom flask was charged with half-ester (100 mg, 0.42 mmol), 5 mL
MeCN, and a stir bar. An aliquot of benzyl bromide (50 µL, 0.42 mmol) was added to
the solution, followed by K2CO3 (58 mg, 0.42 mmol). The solution stirred at room
temperature overnight. The solvent was filtered to remove salts, and the solvent was
removed by rotary evaporation. The material was purified by column chromatography.
Racemic 1-benzyl 3-ethyl 2-methyl-2-((pyridin-2-yl)methyl)malonate (18a):
Racemic 18a was prepared according to the general preparation described for the
synthesis of racemic 18a-c to give the product as a light orange liquid (0.105 g, 0.32
mmol, 76%). Rf = 0.23 (25:75 EtOAc:Hexanes). IR (cm-1) 1727. 1H-NMR (CDCl3, 400
MHz): δ 8.46 (m, 1H), 7.52 (m, 1H), 7.43 – 7.28 (m, 5H), 7.19 – 6.98 (m, 2H), 5.19 (s,
2H), 4.21 – 4.08 (m, 2H), 3.55 – 3.27 (m, 2H), 1.43 (s, 3H), 1.16 (t, J = 7.1 Hz, 3H). 13CNMR (CDCl3, 100 MHz): δ 171.77, 171.71, 157.03, 149.09, 136.04, 135.73, 128.44,
128.16, 128.15, 124.30, 121.62, 66.96, 61.44, 54.19, 43.09, 19.88, 13.91. HRMS:
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[C19H21NO4Na+] calculated = 350.1362, found = 350.1362. The % ee was determined by
chiral HPLC (Chiralcel OJ-H, 262 nm, 4% i-PrOH/hexane, 1 mL/min) Rt1= 26 min, Rt2 =
29 min (0% ee). Note: The % ee of the PLE hydrolyzed products were determined using
HPLC APCI MS.
Racemic 1-benzyl 3-ethyl 2-methyl-2-((pyridin-3-yl)methyl)malonate (18b):
Racemic 18b was prepared according to the general preparation described to
provide the product as a clear viscous material (0.105 g, 0.28 mmol, 66%). Rf = 0.13
(25:75 EtOAc:Hexanes). IR (cm-1) 1727. 1H-NMR (CDCl3, 400 MHz): δ 8.46 (m, 1H),
8.42 – 8.32 (m, 1H), 7.45 – 7.28 (m, 6H), 7.14 (m, 1H), 5.17 (s, 2H), 4.13 (q, J = 7.1 Hz,
2H), 3.22 (s, 2H), 1.38 (s, 3H), 1.14 (d, J = 7.1 Hz, 3H).
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C-NMR (100 MHz, CDCl3) δ

171.31, 151.31, 148.38, 137.56, 135.31, 131.77, 128.57, 128.29, 123.11, 67.19, 61.66,
54.72, 38.42, 19.81, 13.90. HRMS: [C19H21NO4Na+] calculated = 350.1362, found =
350.1362. The % ee was determined by chiral HPLC (Chiracel OJ-H, 262 nm, 5% i-PrOH/hexane, 1 mL/min) Rt1= 22 min, Rt2 = 27 min (0% ee). Note: The % ee of the PLE
hydrolyzed products were determined using HPLC APCI MS.
Racemic 1-benzyl 3-ethyl 2-methyl-2-((pyridin-4-yl)methyl)malonate (18c):
Racemic 18c was prepared according to the general preparation described to give
the product as a light clear viscous material (0.105 g, 0.28 mmol, 66%). Rf = 0.1 (25:75
EtOAc:Hexanes). IR (cm-1) 1727. 1H-NMR (CDCl3, 400 MHz): δ 8.50 – 8.40 (m, 2H),
7.43 – 7.28 (m, 5H), 7.03 – 6.94 (m, 2H), 5.25 – 5.11 (m, 2H), 4.13 (q, J = 7.1 Hz, 2H),
3.21 (d, J = 3.0 Hz, 2H), 1.37 (s, 3H), 1.15 (t, J = 7.1 Hz, 3H). 13C-NMR (100 MHz,
CDCl3) δ 171.24, 149.62, 145.22, 135.25, 128.59, 128.39, 125.47, 67.27, 61.72, 54.42,
40.52, 19.85, 13.89. HRMS: [C19H21NO4Na+] calculated = 350.1362, found = 350.1362.
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The % ee was determined by chiral HPLC (Chiracel OJ-H, 262 nm, 5% i-PrOH/hexane, 1
mL/min) Rt1= 34 min, Rt2 = 97 min (0% ee).
Determination of stereochemistry of 17b:
Half ester 17b (0.10 g, 0.42 mmol), obtained from hydrolysis with PLE 5, was
converted to the amino acid following a similar literature procedure.36 A 50 mL round
bottom flask was charged with of 17b (0.10g, 0.42 mmol), 0.25 mL of water, 0.5 mL of
acetone, and a stir bar. The flask was placed in an icebath and stirred for 10 min. A
solution of Et3N (0.07 g, 0.51 mmol in 2.5 mL acetone) was added dropwise to the flask
at 0 °C. The solution stirred for 5 min at 0°C. A solution of methyl chloroformate (0.06 g,
0.65 mmol in 1 mL acetone) was added dropwise to the flask at 0 °C. The mixture was
allowed to stir at 0 °C for 1 h. A solution of NaN3 (0.045 g, 0.69 mmol in 1 mL H2O) was
added dropwise to the mixture and allowed to stir for 24 h at 0 °C. The solution was
poured into 10 mL cold H2O and extracted with Et2O (25 mL x 3), dried over MgSO4,
filtered, and concentrated under reduced pressure. The crude product was dissolved in
toluene (5 mL) and heated to 100 °C until no further gas evolution was observed
(approximately 2 h). The toluene was removed under reduced pressure, and the resulting
isocyanate was suspended in 7 mL of 2 M HCl and heated under solvent reflux overnight.
The solution was cooled to room temperature, and the pH of the aqueous layer was
adjusted to pH 9. The aqueous layer was extracted with EtOAc to remove any impurities.
The aqueous phase was removed under reduced pressure to provide pure product as a
white solid (0.017g, 0.10 mmol, 23%). Polarimetry was performed in 1 N HCl to
determine the absolute stereochemistry. The levorotatory direction of rotation [α]24˚
D =
-4.23˚ (c 0.26, 1 N HCl) was consistent with that of (R) amino acid.97 This indicates that
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the major enantiomer of 17b must be of the (S) configuration. 1H-NMR (400 MHz, D2O):
8.34 (m, 1H), 8.27 (m, 1H), 7.62 (m, 1H), 7.31 (m, 1H), 3.10 (d, J = 14.2 Hz, 1H), 2.83
(d, J = 14.2 Hz, 1H), 1.35 (s, 3H).
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CHAPTER III
USE OF STRUCTURALLY SIMILAR MOLECULES AS STANDARDS FOR A
MASS SPECTROMETRY ASSAY TO DETERMINE YIELD AND
ENANTIOSELECTIVITY IN A SINGLE ANALYSIS
Hypothesis 2
An external standard that is chemically similar to the substrate of interest can be
added to the LC-MS samples and will enable us to obtain data on both enantioselectivity
and yield data from a single analysis.
Background
A variety of screening methods have been developed in the past several years in
order to accurately calculate the enantiomeric excess (ee) of catalytic reactions. Several
of these methods have been developed to allow for the high-throughput screening of large
libraries of reactions. Several of these methods will be described below, as well as their
applications, strengths, and limitations.
High Throughput methods to determine enantioselectivity
Two of the most common methods to determine the % ee of a reaction are
through polarimetry and chromatographic techniques. However, these methods are
limited in their applications and are often not used as high-throughput techniques.
Polarimetry is concentration dependent, and contaminants can readily alter the results.
Chiral chromatography methods often require long analysis times, resulting in large
consumption of solvent and materials. Furthermore, interfering molecules may be
detected at the same wavelength as the analyte of interest, leading to an incorrect
integration. A multiparallel HPLC method has been developed that allows the analysis of
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a single 96 well plate in a single working day.102 Analysis of the same amount of
samples by typical HPLC analysis would require much longer analysis time.102
Methods which make use of Ultraviolet-Visible (UV-Vis) Spectroscopy detectors
have been utilized to determine % ee; however, it is often more beneficial to use these
methods to obtain kinetic data and gathering data about % ee is not as clear.103 Infrared
(IR) spectroscopy has also been used to determine enantiomeric excess. Samples for this
method, however, require pretreatment by baseline correction using a polynomial
interpolation routine, followed by a normalization step to remove background
interference from the KBr pellet.104 Normalization was accomplished through dividing
the spectra by the absorbance at a particular wavenumber.104 The pretreated data was
then analyzed by several mathematical algorithms, Partial Least Squares Regression
(PLS), and Multivariate Curve Resolution (MCR), to determine the % ee. All of these
additional steps can lead to an error in the determination of enantioselectivity. IR
thermography (IRT) has also been used to determine the % ee of reactions.105,106 IRT uses
an IR camera to visualize the enantiopreference of a catalyst. This method has been
demonstrated to be quick; however, heat detection for a 96 well plate was limited. This
method can be used as a quick pre-screening method for enzymes that should be
evaluated by another method.
One technique that has been frequently employed to determine % ee is nuclear
magnetic resonance (NMR). Often, a chiral derivatizing agent is used to convert the
enantiomers into a pair of diastereomers. The diastereomeric excess (de) is measured by
NMR and can be used to determine the % ee.107 However, use of the chiral derivatizing
agents has several disadvantages. The derivatizing agents must be enantiomerically pure

80
and are often quite expensive. Furthermore, each sample requires additional preparation
prior to analysis. Chiral shift reagents have also been used to calculate the % ee of a
reaction. Chiral shift reagents form diastereomeric complexes on the NMR time scale.
However, using chiral shift reagents often produces spectra that have increased signal
broadening. NMR spectra obtained using chiral shift reagents often have broadened
signals, which leads to inaccurate signal integration and inaccurate % ee.108 Several
NMR techniques have been developed as a high throughput technique screening
techniques for enantioselectivity. In one example developed by Reetz, the methyl group
of one enantiomer of an acetate molecule is enriched with a 12C-label, while the other
enantiomer is enriched with a 13C-label. A 1H-NMR spectrum is obtained, and the % ee
is determined by integration of the singlet resulting from the 12C-label acetate and the
doublet resulting from the 13C-label.109 Later, this assay was improved to use chemical
shift imaging. With this new method, Reetz was able to determine the % ee of up to 5600
samples per day with <5% error.110 However, a major disadvantage to this assay is the
starting materials must be enantiomerically pure leading to higher costs.
Another method used extensively to determine % ee is mass spectrometry (MS).
A method developed by Reetz utilizing gas chromatographic (GC) techniques has
allowed for the determination of % ee of up to 700 reactions per day.111 Other
approaches have made use of liquid chromatography mass spectrometry (LC MS) as a
high-throughput technique for determining % ee.112-119 In one approach, selected
hydrogen atoms of an enantiomerically pure compound are replaced with deuterium
atoms, creating a D3/H3 probe molecule.113 The resulting probe was hydrolyzed to
produce a mixture of pseudo-enantiomeric products. The resulting product mixture was
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analyzed by electrospray ionization mass spectrometry (ESI-MS) to determine the % ee
by using the ratio of the D3 to H3 labeled products. The same experiments were
performed using non-deuterated substrates as control experiments. The products from the
control experiments were analyzed by chiral gas chromatography (GC) to demonstrate
that the results obtained by GC were identical to those obtained from ESI-MS. This
method demonstrates that it is possible to use ESI-MS to determine % ee by using
isotopically labelled starting materials. This method allows for the analysis of up to
10,000 samples per day, with <2% error, and avoids the use of chiral chromatography.113
One of the primary advantages of this technique is that derivatization of samples prior to
analysis is not necessary, eliminating the need for costly chiral derivatizing agents.
Additionally, using an autosampler connected to the ESI-MS allows for a large number of
samples to be analyzed rapidly. Finally, chromatographic separation of the enantiomers
is not necessary because they can be distinguished by their mass labels, cutting down
sample analysis time and cost. However, the major disadvantage to this method is that
the starting probe material must be enantiomerically pure. Obtaining enantiomerically
pure starting material is often time consuming as well as expensive.
An alternative ESI-MS technique was proposed by Masterson, which utilizes
enantiomerically enriched, but not enantiomerically pure probe molecules to study Pig
Liver Esterase hydrolysis reactions for enantioselectivity.15 In this technique, the halfester products from PLE hydrolysis reactions that provide significant but not
synthetically useful enantiomeric excess are recycled as probe molecules through reesterification with deuterated ethanol. Through the re-esterification step, a D5/H5
isotopically labeled probe molecule is synthesized. The probe molecule is then used to
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screen for PLE reaction conditions that provide high enantioselectivity. The
enantioselectivity of the reactions are measured using the ratio of the M to M+5 (nondeuterated product to deuterated product) signal in the ESI-MS. The main advantage of
this method is that half-ester intermediates that would normally be discarded are recycled
and can be used as a probe to explore alternative hydrolysis conditions. Additionally, the
% ee is determined without chromatographic separation, leading to shorter analysis
times.15
All of the methods discussed above allow for the rapid determination of
enantioselectivity. However, the assays described only provide information about the %
ee of the reaction, and information about the yield of the reaction is not obtained. Many
times, a reaction that provides a product with good enantioselectivity will be scaled up,
and the yield measured gravimetrically. However, in some cases it has been found that
reactions that provide good % ee may not provide good yield. For example, Masterson et
al. reported a 90 % ee for a half-ester from PLE hydrolysis with the addition of 30%
isopropanol cosolvent. However, this reaction was repeated on a larger scale to produce
the desired product in a disappointingly low yield of <10%.15 These results introduce the
need for quantification of reaction yield and % ee from a single analysis in a quick and
efficient manner.
Methods of Quantitation
Common methods of quantitation are NMR and MS in addition to traditional
gravimetric analysis. MS quantitation is typically accomplished by the addition of an
internal standard (IS) to a solution of the analyte of interest.120 The quantity of the
analyte is determined by comparing the intensity of the standard to the intensity of the
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analyte. Standards are chosen based on various factors. The standard and analyte should
be similar in their ionization abilities and display similar chromatographic retention
times. Additionally, the masses of the standard and analyte should be at least 3 mass
units different, so the isotopic distribution of the two signals do not overlap.121,122
Quantitative mass spectrometry has been used in various applications, including small
molecule quantitation, protein quantitation, and drug and metabolite quantitation.120,123,124
While there are many applications of quantitative mass spectrometry, it is typically not
used to determine the yield of a reaction. Quantitative NMR (qNMR) has been used to
evaluate the purity and concentration of a sample.125 An internal standard is added to the
NMR sample, and the concentration or purity is determined by comparing the integration
of the standard to the integrations of the analyte.126 Additionally, residual solvent signals
have been used as a reference to determine the concentration of the analyte.127,128
However, like mass spectrometry, qNMR has not been used to determine the percent
yield of a reaction.
Combined Yield and Enantioselectivity Assays
Few assays have been developed that can determine yield and enantioselectivity
in a single analysis. Several strategies involve optical techniques to determine
concentration and % ee in a single assay in a fast and efficient manner. Circular
dichroism (CD) has been used by Nieto et al. to measure concentration and % ee of αchiral amines.129,130 In this method, the amine is first derivatized to the corresponding
imine and then added to a solution of Cu(I)BINAP receptor. A change in the metal to
ligand charge-transfer (MLCT) band in the CD spectra is observed, and the concentration
and % ee were determined through use of a multilayer perceptron artificial neural
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network (MLP-ANN).129 During MLCT, the electron distribution causes a transfer in
energy from the metal to the ligand. CD has also been used to determine the absolute
configuration, concentration and % ee of chiral amino alcohols.131 In this assay, the
chiral amino alcohol binds with a chemosensor containing a salicyclaldehyde substrate
binding unit and a pyridyl N-oxide fluorophore. The binding interaction causes a strong
change in the CD spectrum and the configuration, concentration, and % ee of the chiral
amino alcohol can be determined. While these methods allow for the simultaneous
determination of yield and % ee, each is for a specific type of molecule. Furthermore,
prior sample derivatization is costly and time consuming.
Other groups have developed fluorescence spectroscopy assays for the
simultaneous determination of % ee and yield.132 A chiral N,N’-dioxide-Ni(II) complex
was used as a sensor for chiral amines and amino alcohols. The N,N’-dioxide-Ni(II)
complex exhibited a fluorescent response in the presence of the chiral amine or amino
alcohol. While these assays work well, they are specific to one type of molecule and are
not a general method. New sensors would need to be developed for other molecules.
Other groups have developed indicator displacement assays to determine yield and %
ee.133-136 Like other assays, these were developed for a specific type of molecule.
Additionally, methods such as these require some type of measureable fluorescence or
colorimetric response.
NMR assays have been used to calculate the concentration and % ee of a
reaction.137 Asymmetric transfer hydrogenation reactions were studied using a 13C
isotopically labeled probe molecule. The integrations of the isotope signals of the
product and starting materials were used to determine the conversion and % ee of the
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reaction. For this assay, once the NMR was shimmed on the first sample, the remaining
samples only required 15 seconds for data acquisition. Although this method is
straightforward and high-throughput, it may not be possible to analyze more complex
molecules due to overlapping signals in the NMR spectrum.
An alternative method using GC MS has been described in which the % ee and
conversion are determined for the hydrolysis of ethyl-2-methyl-4,4,4-trifluorobutyrate
with various enzymes.138 The area of the product relative to the sum of the areas of the
product and starting material was used to calculate the percent conversion of the reaction.
However, this method does not measure the absolute yield of the reaction. Additionally,
the response factor of the detector is not taken into consideration. This may cause the
actual yield to vary from the measured percent conversion.
While many of the assays described have been very useful in their applications,
there are also several disadvantages. Many of the assays described were developed for
one specific type of reaction or molecule. Additionally, some of the assays report relative
percent conversion of substrate to product rather than percent yield of the reaction.
While percent conversion gives a good indication of the reaction progress, it cannot
provide the actual yield.
Based on the literature reviewed above, there are several methods to determine
either yield or enantioselectivity, but very few assays that are able to determine both
through a single analysis. Here, improvements to our previously described ESI mass
spectrometry assay are discussed. A molecule structurally similar to the products of the
PLE hydrolysis was chosen as a standard for the reaction. The improvements made to the
assay will allow for the simultaneous determination of % ee and absolution reaction
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yields of Pig Liver Esterase (PLE) hydrolysis reactions through one single analysis
(Scheme 25).15

Scheme 25. Proposed ESI-MS assay to determine yield and enantioselectivity in a single
analysis.
Results and Discussion
The initial assay was performed using three different substrates along with their
corresponding standards (Figure 31). As illustrated in Chapter I, our group has
developed several methods of determining enantioselectivity. However, these methods
are not able to provide information about the yield of the reaction. It was found that this
method can reasonably predict both yield and enantioselectivity of PLE hydrolysis
reactions with both crude PLE and PLE isoenzymes.
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Figure 31. Products of PLE Hydrolysis reactions (2, 19, 20) and corresponding standards
(21, 22, 6). Each standard differs from the corresponding reaction product by one
methylene unit.
Choice of Standard
The standards were all chosen based upon the requirements discussed above for
internal standards. The standards chosen are all structurally similar to the products of
PLE hydrolysis reactions. Each of the standards differs from the corresponding analyte
by one methylene unit, corresponding to a difference in 14 mass units. The two species
are distinguishable by mass; therefore, chromatographic separation of the two is not
necessary. Furthermore, each set of product and standard contains the same functional
group and therefore should have similar ionization properties.

88
Ionization Efficiency
The ionization efficiency of the standard and the reaction products were analyzed
prior to each assay. A set of standard curves were prepared using the desired acid-ester
product and its corresponding standard. For product 2 and standard 21, a linear
correlation (R2 = 0.9936) was observed between intensity and concentration, with a slope
of 1.7. A linear correlation (R2 = 0.9968) between intensity and concentration was also
observed for product 19 and standard 22, with the slope of the standard curve calculated
to be 1.6. In both cases, the fit of the line was excellent, indicating a good correlation
between concentration and intensity. The slopes indicate that the ethyl acid-ester is able
to ionize more efficiently in comparison to the methyl acid-ester.
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Figure 32. Standard curves for assays 1 and 2. Assay 1 utilized 21 as the standard and 2
as the products of the hydrolysis reaction. The standard curve for assay 1 is shown in
orange. Assay 2 utilized 22 as the standard, and 19 was the product of the hydrolysis
reactions. The standard for assay 2 is shown in blue.
In the final series, the ethyl acid-ester was used as the standard while the methyl
acid-ester was the product of the reaction (Figure 33). A standard curve was prepared for
these molecules as well. Again, a linear correlation was observed (R2 = 0.9896) with a
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slope of 0.8. This indicates again that the ethyl acid-ester ionizes more efficiently
compared to the methyl acid-ester. Additionally, there is a strong correlation between the
concentration and intensity.
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Figure 33. Standard curve for assay 3. Assay 3 used standard 6 and acid-ester product
20.
In all three cases, the ethyl acid-ester displayed a higher ionization efficiency
compared to the methyl acid ester, as indicated by the slope of the line on the standard
curve. A value close to 1.0 for the slope would indicate that the standard and the acidester products ionize with the same efficiency. Other research groups have found that the
ionization efficiencies increase as the alkyl chain length increases.139,140 Yang reported
the ionization efficiency was improved in the derivatization of amino acids with various
hydroxysuccinimide ester of N-alkylnicotinic acid (Cn-NA-NHS) when longer alkyl
chain length derivatizing agents were used. For example, lysine derivatized with C4-NANHS resulted in approximately a 6 fold improvement of signal enhancement compared to
the intensity of lysine derivatized with NA-NHS.140 Yang proposed that the hydrophobic
nature of the molecule increased as the alkyl chain length was lengthened. The increased
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hydrophobicity leads to a higher concentration of the amino acid at the droplet surface in
the ESI-MS. The increased concentration results in a higher ionization efficiency of the
molecules containing longer alkyl chains.140 Our results are consistent with the
observations of Yang. As the chain length increased from methyl to ethyl, the ionization
efficiency was increased.
Mass Spectrometry Assay to Determine Yield and Enantioselectivity
Assay 1. The first assay was conducted with probe molecule 1 (Scheme 26).
Cosolvent studies were previously conducted with this substrate and the PLE isoenzymes
as illustrated in Chapter II. However, using our previous assay, we were only able to
obtain data about the % ee of the reactions.

Scheme 26. PLE Hydrolysis Assay for Probe-1
All of the ions were detected as sodium adducts [M+Na] (Figure 34). The
hydrolysis of probe 1 with PLE 3 is shown in Figure 34. The ratio of relative intensities
of (R)-2 to (S)-2 were used to calculate the enantioselectivity of the reaction based on our
previously reported assay.15 The yield was calculated by taking the ratio of the sum of
(R)-2 to (S)-2 to 21 for the total concentration of 2 in solution. The concentration of 2
was then converted to a percent yield for the reaction. In Figure 34, the half-ester
product 2 was produced as the (S)-enantiomer in 60% yield. Interestingly, the retention
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time of 2 (2.19 min) was slightly longer than the retention time of 21 (1.81 min). Figure
35 displays the total ion chromatogram (TIC) and reconstructed ion chromatogram (RIC)
for each of the detected ions.

21
2

2

Figure 34. LC MS analysis in SIM mode for the three ions detected.
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Figure 35. Total Ion Chromatogram (TIC) and Reconstructed Ion Chromatograms (RIC)
for each of the ions.
For each assay, the concentration of the acid-ester product was converted to a
percent yield for each reaction. The percent yields and % ee for the hydrolysis reactions
of 7 with crude PLE and PLE isoenzymes are displayed in Figure 36. The average of
three reactions is plotted, and the error bars indicate the standard deviation in the three
values. With the exception of PLE 1, all of the enzymes produced the desired product in
acceptable yields (>50%). Crude PLE provided the highest yield, giving the desired acidester product in approximately 70% yield. Isoenzymes 2-6 all produced the acid-ester
product in similar yields of approximately 60%. PLE 1 produced the acid-ester product
in disappointingly low yield of only approximately 20%. The enantioselectivites of these
reactions were all consistent with that of previously reported data.44 Crude PLE, PLE 1,
and PLE 2 all produced the acid-ester product as predominantly the (R)-enantiomer,
while PLE 3, PLE 4, PLE 5, and PLE 6 all produced predominantly the (S)-enantiomer.
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Interestingly, PLE 1 provided the highest enantioselectivity (90% ee, R-enantiomer) but
the lowest yield (20% yield). Also interesting to note is that crude PLE, which provided
the highest yield (70%), only provided the (R)-enantiomer in 23% ee. Crude PLE is
known to contain various amounts of PLE 1-6 so this may account for the low
enantioselectivity observed in the hydrolysis of probe 1 with crude PLE.13
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Figure 36. Percent yields and enantioselectivities for the hydrolysis of probe 1. Yields
are shown in black bars. % ee is displayed in gray bars. Positive % ee depicts
predominantly (R)-enantiomer; negative % ee depicts predominantly (S)-enantiomer.
Next, the PLE hydrolysis reactions of probe 23 were studied (Scheme 27). It has
been previously reported that the number of methylene units in the side chain alters the
enantioselectivity of the PLE hydrolysis reaction.11 Banerjee et al. reported that the
enantioselectivity of the hydrolysis reaction improved as the number of methylene units
in the side chain increased from one to three in the crude PLE hydrolysis of prochiral
malonate diesters. However, an increase in the number of malonate units past three
resulted in a decrease in enantioselectivity.11 Previously, only the hydrolysis reaction
with crude PLE was performed with this substrate. Probe 23 was selected for the next
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assay to determine if the isoenzymes would also produce high enantioselectivities similar
to hydrolysis with crude PLE. Additionally, we were interested to determine if the
reactions that produced high enantioselectivity also produced the desired product in high
yields. A similar assay to the one previously described was performed with probe 23.
Once the reactions were complete, an aliquot of the standard solution 22 was added to
each reaction as illustrated in Scheme 27.

Scheme 27. PLE Hydrolysis assay for probe 8.
The yields and enantioselectivities were calculated in the same fashion as
previously described. PLE 2 produced the product in the highest yield of approximately
60%. PLE 1 provided the product in a disappointingly low yield of <10%. Crude PLE
also provided the product in a low yield of approximately 30%. PLE isoenzymes 3-6
displayed very similar yields of approximately 50%. The enantioselectivities of the
hydrolysis reactions of probe 23 were also determined by this assay. All of the
isoenzymes produced the (R)-enantiomer as the predominant product. Even more
interesting, the enantioselectivities displayed for each enzyme were greater than 90% for
the hydrolysis of probe 23 (Figure 37). The Jones Active Site Model for PLE can be used
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to explain the high enantioselectivities observed.67 Banerjee et al. have reported a similar
trend in enantioselectivities when the number of methylene units in the side chain was
increased.11 They have proposed that the longer length side chain is better able to fit into
the hydrophobic large pocket. The enantioselectivity is increased because the molecule is
better able to fit into the active site of the enzyme.

Figure 37. Yields and enantioselectivities for PLE hydrolysis reactions of probe 23.
Lastly, the assay was performed with probe 9 (Scheme 28). For this assay, the
hydrolysis of the methyl diester probe (9) was studied. The standard for the assay was
the ethyl acid-ester molecule (6). From previous work, the hydrolysis of the ethyl diester
provided moderate enantioselectivities with some of the isoenzymes.44 It was of interest
to determine if the hydrolysis of the methyl diester would provide similar
enantioselectivities to the hydrolysis of the ethyl diester.

96

Scheme 28. PLE hydrolysis assay for probe 24.
The yields and enantioselectivities of the hydrolysis reactions of probe 24 are
displayed in Figure 38. PLE 3 and PLE 5 afforded the highest yields of approximately
80%. Crude PLE and PLE 6 also provided the products in good yields of 70%. PLE
isoenzymes 1 and 2 provided the product in very poor yield, with only 10% of the
product being formed. Interestingly, Crude PLE, PLE 5, and PLE 6 all provided the (S)enantiomer predominantly, while PLE 1, PLE 2, PLE 3, and PLE 4 provided the (R)enantiomer predominantly. The highest enantioselectivites were observed for the
hydrolysis reactions with PLE 2 (50% ee, (R)-enantiomer) and PLE 5 (60% ee, (S)enantiomer). Several of the other enzymes, such as crude PLE, PLE 1, and PLE 6,
provided enantioselectivities just below 50%. PLE 3 and PLE 4 displayed low
enantioselectivity for the hydrolysis of probe 24. However, it is known that this type of
diester does not typically afford very high enantioselectivity in PLE hydrolysis reactions.
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Figure 38. Yields and % ee for the PLE hydrolysis reactions of probe 24. Grey bars
display percent yields. Black bars depict % ee. Negative values indicated (S)enantiomer.
The yields for three separate hydrolysis reactions were determined through the
use of a standard that was structurally similar to the products of the PLE hydrolysis
reactions. From this data, it is clear that the assay is able to distinguish yields over a wide
range, from yields of 10% up to 80%. In all cases, PLE 1 provided very poor yield
(<10%). Furthermore, the data is consistent within each set, resulting in only small
deviations for the three reactions. The data from this assay as well as the other two
assays indicate that this assay is able to predict the yields of reactions with high yields as
well as those with low yields.
Ability of the assay to accurately predict reaction yields.
The yields and % ee for the three separate hydrolysis reactions were determined
using a mass spectrometry assay. Reactions were performed on a larger scale to
determine if the assay could accurately predict the isolated yields of the PLE hydrolysis
reactions performed on the preparative scale. Each hydrolysis reaction was performed
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using 100mg of the starting probe molecule. The probe molecule was placed in pH 7.4
phosphate buffer, and crude PLE enzyme was added. After the reaction was complete,
the product was extracted from the buffer solution and worked up according to traditional
workup procedures. The yield of each reaction was determined by gravimetric analysis.
Each hydrolysis reaction was performed in triplicate, and the average yield and standard
deviation were plotted (Figure 39). The yields determined from the assays are plotted for
comparison.
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Figure 39. Yields for preparative scale reactions (grey bars) and yields determined from
the assay (black bars). The yields are plotted as the average yield of three reactions. The
error bars represent the standard deviation between the three reactions.

The isolated yield for the hydrolysis reaction of probe-1 with crude PLE was
determined to be 66%. The assay predicted the yield of the reaction to be approximately
72%. Although the assay predicted the yield to be slightly higher than the actual
observed yield, the assay was able to provide a good approximation of the yield. It is
important to note that the products of the preparative scale reactions were extracted,
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filtered, and purified prior to gravimetric analysis to determine the yield of the reaction.
Yields determined by the assay were obtained without performing any of these
manipulations. The isolated yields may be lower than the predicted yields from the assay
due to the addition of all the extra steps.
The isolated yield for the hydrolysis reaction of probe-23 with crude PLE was
determined to be approximately 29%. This value is in good agreement with the yield
predicted by the assay (30%). However, this yield is significantly lower than the yield
obtained from the hydrolysis of probe-1. This result indicates that the assay is able to
distinguish reactions producing low yields from reactions producing high yields and
provide reasonable approximations of the isolated yields of preparative scale reactions.
The assay predicted the yield of the hydrolysis reaction with probe-24 and crude
PLE to be 71%. The average isolated yield was determined to be 86%. While the
isolated reaction yield is higher than the predicted yield, it is within the range of
experimental error predicted by the assay.
For all three substrates, the assay is able to provide an approximation of the
isolated yield for the preparative scale reactions. Overall, there was a 9.2% error between
the isolated yields and the assay yields. While the assay yields were found to vary
slightly from the yields determined by the assay, they were all within the experimental
error of the assay.
Conclusions
Molecules that are structurally similar to products produced from PLE hydrolysis
reactions have been used as standards to determine both yield and enantioselectivity of a
reaction in a single assay. Prior to each new assay, a standard curve was prepared. In
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doing so, the relative ionization efficiencies of the standard and the reaction product were
studied. In all three cases, the ethyl acid ester ionized more efficiently than the methyl
acid ester. A response factor of 1.0 would indicate that the standard and acid-ester
product ionize similarly. Although the response factor was not 1.0 as expected, it can be
taken into account when determining the yield of the reaction. However, since the
response factor varied for each assay, a standard curve must be prepared prior to each
new assay performed.
This assay eliminates the need for extensive post reaction derivatization. The
standards are synthesized using straightforward chemistry and can be obtained in as little
as two steps. Furthermore, the standards can be synthesized in racemic form, cutting
down on preparation and separation costs. The assay is able to provide the absolute yield
of the hydrolysis reaction, rather than a percent conversion relative to the amount of
starting material. The yields determined in the assay provide a reasonable approximation
for the yields of the reaction performed on a preparative scale (Figure 37).
The improvements made to our previously reported assay allow for the
simultaneous determination of yield and enantioselectivity in a single analysis. This
improvement eliminates the need to perform multiple reactions on a preparative scale to
determine the yield of the reaction. This method will be a useful tool to screen reaction
conditions for combinations that afford both high yield and enantioselectivity. Only
those reactions that provide both high yield and high enantioselectivity would be
performed on a preparative scale, saving time and laboratory materials. Typical analysis
times were 7 min per sample including time for column equilibration and column
flushing. The analysis of up to 204 samples could be completed in a 24 h period through
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use of an autosampler under these conditions. The HPLC column was used for
separation of the standard and reaction product. Analysis time could be shortened by
varying the HPLC conditions. While only PLE hydrolysis reactions were considered for
this dissertation, this method can be extended to screen the results of other enzymatic
reactions.
Experimental
Mass Spectrometry General Procedure
Mass spectrometry was carried out using a ThermoFisher LXQ ESI-Ion trap mass
spectrometer coupled to a ThermoFisher Accela HPLC system. The Accela auto sampler
was set to inject 2 µL of solution onto a Hypersil Gold Reverse Phase (RP) HPLC
column (50 x 2.1 mm, ThermoFisher). The solvent system was 60:40 MeOH:H2O (v/v)
at a flow rate of 100 μL/min. The solvents each contained 1% acetic acid and
approximately 10 small crystals of NaCl per liter as charging agents. The mass
spectrometer was set to detect in selected-ion monitoring (SIM) mode, and the intensities
of the ions were used to determine enantioselectivity and yield of the reactions.
General Procedure for Enzyme Assays
A stock solution of the diester “probe” was prepared by dissolving the diester of
interest in 2-propanol (i-PrOH). This solution was pipetted into a set of Eppendorf tubes
such that the final amount of probe in each tube was 1.5 mg. The i-PrOH was evaporated
under a stream of nitrogen gas prior to the assay. After evaporation of the i-PrOH, 1 mL
of pH 7.4 phosphate buffer was added to each tube. Stock solutions of the various PLE
isoenzymes were prepared in 3 M (NH4)2SO4. An aliquot of the PLE solution under
study was added to each tube (0.5 units total). The Eppendorf tubes were placed into a
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Thermomixer® for three days, at 25°C and 1400 RPM mixing rate. After this time
period had elapsed, a 200 µL aliquot of a stock solution of the standard was added to
each tube and mixed. A 400 µL aliquot of the solution containing the standard and
reaction products was placed in an autosampler vial and analyzed by HPLC MS as
previously described.15,44
Preparation of Stock Solutions of Standards and Reaction Products
Stock solutions of each standard were prepared by placing the desired standard in
a volumetric flask. Standard solution 21 was prepared by dissolving 0.07 g (0.25 mmol)
in 25 mL of pH 7.4 phosphate buffer to give a standard solution with a concentration of
9.9 mM. Standard solution 22 was prepared by dissolving 0.12 g (0.37 mmol) in 25 mL
of pH 7.4 phosphate buffer to give a standard solution with a concentration of 14.9 mM.
Standard solution 6 was prepared by dissolving 0.11 g (0.46 mmol) in 50 mL of pH 7.4
phosphate buffer to give a standard solution with a concentration of 9.2 mM.
Stock solutions of each reaction product were prepared by placing the acid-ester
of interest in a volumetric flask. The solution of 2 was prepared by dissolving 0.21 g
(0.70 mmol) in 25 mL of pH 7.4 phosphate buffer to give a solution with a concentration
of 13.9 mM. The solution of 19 was prepared by dissolving 0.21 g (0.62 mmol) in 50 mL
of pH 7.4 phosphate buffer to give a solution with a concentration of 12.5 mM. The
solution of 20 was prepared by dissolving 0.10 g (0.47 mmol) in 50 mL of pH 7.4
phosphate buffer to give a solution with a concentration of 9.4 mM.
Preparation of a Standard Curve to Determine Ionization Efficiency
A standard curve was prepared to determine the response factor of the instrument
for each set of product and standard. Preparation of the stock solutions of the standards
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and reaction products are detailed above. A series of 10 solutions were prepared to
determine the response factor of the instrument. These solutions were prepared so that
the molar ratio of acid-ester products to standard in each solution ranged from 0.1 to 1.1.
The solutions were then analyzed by mass spectrometry as outlined previously. The
relative intensity of the acid-ester products, referred to as Iproducts, and relative intensity of
the standard, Istandard, were recorded. To determine the instrument response factor,
Iproducts/Istandard was plotted against the ratio of [products]/[standard]. The slope of the line
represents the ionization response factor of the instrument and was taken into account
when the yields of the reaction were calculated. Each solution was prepared in triplicate
and analyzed. The data was plotted as the average of the three analyses and the error bars
are the standard deviations of the three analyses.
Data analysis
The data obtained was imported into Xcalibur® software. The ion chromatogram
was smoothed using the boxcar fitting, 15 points. The data was averaged, and the
intensities of the analyte and standard were recorded. The enantioselectivity of the
reactions were calculated according to the method previously reported by Masterson.15
The percent yield was obtained by first calculating the concentration of the
products in solution, denoted by [products]. The concentration of products was
calculated using the linear relationship that exists between [products]/[standard] and
Iproducts/Istandard obtained from preparation of a standard curve. This relationship is shown
in Equation 1. In this case, y is the ratio of Iproducts/Istandard, m is the slope of the line
obtained from the standard curve (response factor), and x is the ratio of concentrations
[products]/[standard].
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Equation 1. Relationship between intensity and concentration
Iproducts
Istandard

[products]

= m [standard] + b

The equation can be rearranged to determine the concentration of the product in
solution shown in Equation 2.
Equation 2. Rearrangement of equation 1 to solve for the concentration of products.
Iproducts

[products] =

[standard][(

Istandard

)-b]

m

The number of moles in solution was calculated by multiplying the concentration
by the total volume of solution. Finally, the yield was calculated by dividing the total
moles in solution by the number of starting moles and multiplying by 100% to obtain the
% yield, shown in Equation 3.
Equation 3. Equation used to calculate % yield of the hydrolysis reaction.
%Yield =

molesinsolution
initialmoles

*100%

Synthesis
Compounds 2, 9, and 20 were synthesized according to a published literature procedure.
Characterization matches those of published literature values.44,11,141
2-(methoxycarbonyl)-2-((1,3-dioxoisoindolin-2-yl)methyl)propanoic acid (21):
The starting diester (1.0 g, 3.28 mmol) was dispersed in 250 mL pH 7.4 phosphate
buffer (0.1 N). A suspension of crude PLE (17 mg, 295 units) in 3 M (NH4)2SO4 was
added to the buffer solution. The pH of the reaction solution was maintained at 7.4 using
a Radiometer Analytical TIM 854 Automatic Titrator. The titrator was set to deliver a
volume of 3.2 mL 1.0 M NaOH (1 equivalent). The reaction stirred for four days until 1
equivalent of 1.0 M NaOH had been added. After the reaction was over, the solution was
stirred with Celite® and filtered. The solution was extracted three times with 100 mL
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portions of Et2O to remove any unreacted diester. The solution was acidified to pH 4
with concentrated H2SO4. The aqueous layer was extracted with three 100 mL portions
of Et2O. The organic layer was dried over MgSO4, filtered, and concentrated under
reduced pressure. The material was purified by passing through a silica bed using 5:95
MeOH:CH2Cl2 to provide the product as a pure white solid (0.41 g, 1.41 mmol, 43%).
MP: 164-165 ˚C Rf: 0.625 (15:85 MeOH:CH2Cl2). 1H-NMR (400 MHz, CDCl3): 7.86
(m, 2H), 7.74 (m, 2H), 4.29 (d, 2H), 3.85 (s, 3H), 3.51 (s, 3H); 13C-NMR (100 MHz,
CDCl3): 171.31, 170.88, 168.23, 134.27, 131.75, 123.58, 53.46, 53.23, 41.10, 18.46. IR
(cm-1): 2955, 1752, 1699. HRMS: [C14H13NO6Na+] calculated = 314.0635;
found = 314.0635.
2-(methoxycarbonyl)-2-methyl-5-(1,3-dioxoisoindolin-2-yl)pentanoic acid (22):
The starting diester (2.01 g, 6.03 mmol) was dispersed in 250 mL pH 7.4
phosphate buffer (0.1 N). A suspension of crude PLE (28.4 mg, 568 units) in 1.0 mL of 3
M (NH4)2SO4 was added to the buffer solution. The pH of the reaction solution was
maintained at 7.4 using a Radiometer Analytical TIM 854 Automatic Titrator. The
titrator was set to deliver a volume of 6 mL 1.0 M NaOH (1 equivalent). The reaction
stirred for four days until 1 equivalent of 1.0 M NaOH had been added. After the
reaction was over, the solution was stirred with Celite® and filtered. The solution was
extracted three times with 100 mL portions of CH2Cl2 to remove any unreacted diester.
The solution was acidified to pH 4 with concentrated H2SO4. The aqueous layer was
extracted with three 100 mL portions of CH2Cl2. The organic layer was dried over
MgSO4, filtered, and concentrated under reduced pressure to give the product as a clear
viscous oil. (0.89 g, 2.79 mmol, 46.3 % yield). Rf: 0.83 (20:80 MeOH:CH2Cl2). 1H-NMR
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(400 MHz, CDCl3): 7.84 (dd, J = 5.5, 3.0 Hz, 2H), 7.72 (dd, J = 5.5, 3.0 Hz, 2H), 3.73 (s,
3H), 3.70 (t, J = 7.1 Hz, 2H), 2.05 – 1.81 (m, 2H), 1.69 (tdd, J = 9.2, 7.9, 4.5 Hz, 2H),
1.44 (s, 3H). 13C-NMR (100 MHz, CDCl3): 176.82, 172.43, 168.38, 133.99, 132.06,
123.29, 53.32, 52.78, 37.89, 32.90, 23.77, 20.22. IR (cm-1): 3200-3100, 2951, 1770,
1701. HRMS: calculated [C16H17NO6Na+] = 342.0948; found = 342.0947.
Synthesis of Probe 23:
A 100 mL round bottom flask was charged with 2 (0.803 g, 2.4 mmol, 97% ee),
50 mL anhydrous CH2Cl2, and a stir bar. Thionyl chloride (3.0 mL, 36 mmol) was added
to the flask, and the solution was set to reflux under nitrogen for 48 h. The solution was
concentrated under reduced pressure to remove excess SOCl2. The resulting acid
chloride was dissolved in 50 mL anhydrous CH2Cl2. A solution containing anhydrous
Et3N (368 µL, 2.4 mM) and 1 mL ethanol-d6 was added drop wise to the acid chloride
under N2 atmosphere and set to stir overnight at room temperature. The resulting mixture
was diluted with 30 mL Et2O and washed three times each with 1.2 M HCl followed by
1.0 M NaOH. The organic layer was dried over MgSO4, filtered, and concentrated under
reduced pressure to give the product as a clear viscous oil (0.63 g, 1.7 mmol, 71% yield).
Rf: 0.20 (30:70 EtOAc:Hexanes). IR (cm-1): 2940, 1772, 1707, 16151. 1H-NMR (400
MHz, CDCl3) 7.84 (m, 2H), 7.71 (m, 2H), 4.16 (q, J = 7.1 Hz, 2H), 3.69 (t, J = 7.2 Hz,
2H), 1.95 – 1.86 (m, 2H), 1.66 (m, 2H), 1.39 (s, 3H), 1.23 (t, J = 7.1 Hz, 3H). 13C-NMR
(100 MHz, CDCl3): 172.04, 168.28, 133.93, 132.13, 123.23, 61.29, 53.36, 38.01, 32.69,
23.70, 19.96, 14.02. HRMS: Calculated [C19H18D5NO6Na+] = 389.1731 found =
389.1729.
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Synthesis of Probe 24:
A 25 mL round bottom flask was charged with 3 (0.56 g, 2.5 mmol, 93.5% ee), 15
mL anhydrous CH2Cl2, and a stir bar. Thionyl chloride (2.7 mL, 37.5 mmol) was added
to the flask, and the solution was set to reflux under nitrogen for 18 h. The solution was
concentrated under reduced pressure to remove excess SOCl2. The resulting acid
chloride was dissolved in 15 mL anhydrous CH2Cl2. A solution containing anhydrous
Et3N (385 µL, 2.5 mM) and 1 mL methanol-d4 was added drop wise to the acid chloride
under N2 atmosphere and set to stir overnight at room temperature. The resulting mixture
was diluted with 15 mL Et2O and washed three times each with 1.2 M HCl followed by
1.0 M NaOH. The organic layer was dried over MgSO4, filtered, and concentrated under
reduced pressure to give the product as light yellow solid (0.525 g, 2.2 mmol, 88% yield).
Rf: 0.42 (30:70 Et2O:Hexanes). MP: 61-62 ˚C. IR (cm-1): 1728, 1713. 1H-NMR (400MHz, CDCl3) 7.26 (m, 3H), 7.10 (m, 2H), 3.73 (s, 3H), 3.22 (s, 2H), 1.35 (s, 3H). 13CNMR (100 MHz, CDCl3): 172.16, 136.10, 130.13, 128.22, 126.96, 55.14, 52.60, 19.70,
14.29. HRMS: [(C13H13D3O4)2Na+] calculated = 501.2366, found = 501.2363.
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CHAPTER IV
EVALUATION OF AN UNNATURAL GLUTATHIONE DISULFIDE ANALOGUE
FOR GLUTATHIONE REDUCTASE INHIBITION
Hypothesis 3
Disulfide bonds are known to rapidly degrade in vivo. Peptides that have
unnatural cysteine analogues incorporated may exhibit increased stability in vivo against
reductase enzymes
Background
Several covalent and non-covalent interactions dictate the structure of proteins
and peptides. One of the most important interactions are disulfide bonds. Disulfide
bonds are covalent bonds formed between two sulfur atoms, typically the thiol group of
the cysteine amino acid (Figure 40). When formed, the disulfide bond can impose certain
angle and distant constraints on the carbon and sulfur atoms of the two cysteine
residues.142

Figure 40. Naturally occurring cysteine amino acid (left) and general schematic of
disulfide bond (right).
Disulfide bonds are rapidly degraded in vivo. A protein loses much of its stability
once the disulfide bond is broken.143 Various strategies have been employed to
synthesize disulfide bond mimics to combat disulfide bond degradation. These strategies
as well as their strengths and limitations will be discussed.
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Disulfide Bond Mimetics to Improve the Stability of the Disulfide Bond
Several strategies have been employed to improve the stability of the disulfide
bond. Some of these strategies and their strengths and limitations are described below.
Replacement of disulfide bond with thioether bond. One of the most attractive
alternatives to a disulfide bond is replacement of the disulfide bond with a thioether
linkage. In many cases, a cystathionine (Cth) linkage is used, in which one sulfur atom
of the disulfide bond is replaced with a methylene (–CH2-) unit. This substitution results
in a carbon to sulfur bond that is resistant to reductases. Analogues of oxytocin,
vasopressin, and several other biologically relevant peptides have been synthesized
through this method.144-148
In one example, analogues of Compstatin were synthesized through solid phase
polypeptide synthesis (SPPS).149 The inhibitory activity and binding to substrate c3b was
subsequently studied. It was found that these analogues still maintained binding affinity
for the c3b as well as potent inhibitory properties when compared to the control
compstatin analogue.149 However, it was also found that the location of the new
cystathionine bond has effects on the properties of the peptides. In one case, the sulfur
atom nearest the C-terminal side was replaced with a methylene unit producing the δcystathionine (δ-Cth) linkage. The analogue containing the δ-Cth linkage was able to
maintain inhibitory and binding properties similar to those of the parent disulfide
compstatin.149 In comparison, replacing the sulfur atom closer to the N-terminal side
produced the γ-Cth linkage, and these analogues did not maintain the same inhibitory and
binding properties.149
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Figure 41. Natural Compstatin and two analogues. Analogue 1 shows the sulfur closer to
the C terminal side replaced with a methylene unit, forming the γ-Cth linkage. Analogue
2 shows the sulfur closer to N terminal side replaced with a methylene unit, forming the
δ-Cth linkage.
Replacement of disulfide with diselenide bond. Several analogues of oxytocin
have been synthesized in which the disulfide bond was replaced with either a diselenide
or selenide-sulfide bond (Figure 42).150 The two selenide-sulfide analogues retained
biological activity; however, a 10 fold decrease in efficacy was observed for one of the
analogues (EC50 = 154 nM) compared to that of natural oxytocin (EC50 = 15 nM).150 The
diselenide analogue displayed a similar efficacy (EC50 = 18 nM) to that of natural
oxytocin; however, the binding affinity was decreased 10-fold (Ki = 11.8 nM) as
compared to natural oxytocin (Ki = 0.79 nM).150

Figure 42. Natural oxytocin and three analogues synthesized by Muttenthaler.150
Replacement of the Disulfide Bond with Carbon-Carbon Bonds. The stability of
the disulfide bond has been improved by replacing the disulfide bond with alkane, alkene,
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or alkyne functional groups. The synthesis of several orthogonally protected disulfide
bond mimics has been reported by Tadd et al. (Figure 43).151 These mimics utilize an
internal carbon-carbon bond. The mimics containing an alkene and alkyne are of
particular interest. Since alkenes and alkynes cannot freely rotate around the double or
triple bond, a peptide substituted with one of these mimics may become constrained in
one particular conformation. The stability of a peptide may be improved by replacing the
disulfide bond with one of these mimics.

Figure 43. Orthogonally protected disulfide bond mimics.
Stymiest has reported the synthesis of several oxytocin analogues in which the
disulfide bond was replaced with a carbon analogue.152-154 In one strategy, the cysteine
residues were replaced with allylglycine, and ring closing metathesis (RCM) was
performed with a Grubbs ruthenium based catalyst to form the cyclic peptide.152 Several
of the analogues were tested for biological activity in rat uterus strips. All analogues
tested produced a larger EC50 value than that of oxytocin, indicating that these analogues
were not as potent as oxytocin (Figure 44).152 Oxytocin analogues have been synthesized
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in which the ring size has been expanded. Although these analogues show reduced
activity, they also show an increased half-life compared to that of native oxytocin.153

Structure
Oxytocin
Cis C=C
Trans C=C
C-C

EC50 (ng/mL)
2.7
38
242
338

Figure 44. Comparison of EC50 values for oxytocin and several mimics.
The disulfide bond of several biologically active peptides have been replaced with
carbon analogues. In several cases, the half-life of the peptide has been improved, but the
potency of the analogue decreased.152,153 Recently, several analogues of “C-4” have been
synthesized.155 C-4 has been found to increase the activity of kallikrein-related peptidase
3 (KLK3), a serine protease.156 The analogues featured an alkene functionality in place
of the disulfide bond. The alkene was formed in a 1:1 E/Z isomeric ratio using ring
closing metathesis chemistry.155 The activity of KLK3 was increased with several of the
analogues. The increase in activity of KLK3 was not as large as with C-4. 155
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Replacement of disulfide bonds with azo-bridges. A mimic of somatostatin-14
(SST-14) has been synthesized in which the disulfide bond is replaced with an azo-bridge
(Figure 45. SST-14 (left) and the azo-analogue (right).).157 The Cys3 residue was
replaced with p-amino phenylalanine, and the Cys14 was replaced with either a histidine
(His) residue or a tyrosine (Tyr) residue. The azo bridge of the cyclic peptide was
synthesized using literature procedures.157-159 The binding affinities of each analogue to
the SST receptor 2 (SSTR2) were determined using the SST2 expressed on rat acinar
pancreatin carcinoma AR4-2J cell membranes.157 Each analogue displayed good to
moderate affinity to the rat SST2 (Figure 45).

Figure 45. SST-14 (left) and the azo-analogue (right).
Backbone metal cyclization as disulfide replacements. The synthesis of
approximately 50 SST analogues in which a rhenium (Rh) chelating metal atom has been
incorporated into the disulfide bond has been reported.160 Binding affinities for the RhSST analogues were evaluated using human SSTR2. All of the synthesized Rh-SST
analogues displayed moderate to high in vitro binding affinities. Further, five of the RhSST cyclic analogues displayed IC50 values between 1 to 3 nM, indicating their possible
future application as radiolabeled agents.160
Limitations to these methods. The literature reviewed above describes the wide
range of disulfide bond mimics that have been used to improve the stability of disulfide
containing peptides. In each case, the disulfide bond is completely replaced. However,
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replacement of the disulfide bond can have negative implications for the stability and
biological activity of the peptide. When a disulfide bond is formed, angle and distant
constraints are impose on the carbon and sulfur atoms of the disulfide bond, presumably
due to the sulfur atom.142 The structure of a protein is stabilized through the formation of
inter- and intramolecular disulfide bonds. Disulfide bonds also improve the rigidity of
proteins by stabilizing secondary structures such as β-sheets.143 All analogues described
previously disrupt the disulfide bond and thus no longer have the features or stability that
may be exhibited because of the disulfide bond, which may dramatically alter activity in
some cases.161 For example, Zhang et al. found that replacing one or both Cys residues
with Ser in human insulin-like 3 (INSL3) protein led to retention of binding ability;
however, receptor activation was diminished with these analogues.162
Keeping cysteine intact. As mentioned in Chapter I, several analogues of cysteine
have been synthesized in recent years. Kedrowski reported the synthesis of both
enantiomers of α-methyl cysteine in good yield and enantioselectivity (Scheme 29).42
This synthesis was accomplished through a series of straightforward organic
transformations. Key steps include PLE catalyzed desymmetrization of the starting
diester followed by Curtius rearrangement.
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Scheme 29. Synthesis of both enantiomers of -methyl cysteine by Kedrowski.
In 2008, Masterson et al. reported the synthesis of both enantiomers of β2,2 and
β3,3 cysteine analogues through a series of straightforward organic procedures (Scheme
30).12 Key steps in the synthesis of the β2,2 analogues were PLE catalyzed hydrolysis of
the prochiral malonate diester, to produce the acid-ester in 81% ee and 76% yield,
followed by a photo-Wolff rearrangement and a Curtius rearrangement. Manipulation of
the protecting group of the (R)-half ester followed by the same series of steps produced
the (S)-enantiomer of β2,2 cysteine. Furthermore, the β3,3 analogues were also synthesized
using similar chemistry.

Scheme 30. Synthesis of both enantiomers of 2,2 cysteine analogues by Masterson.
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In 2010, Masterson et al. reported the incorporation of (R)-α-methyl cysteine
analogue into the tripeptide glutathione (GSH), in an overall yield of 21% (12 steps) and
91% ee (Scheme 31).43 Both reduced and oxidized forms of glutathione were synthesized
through this method. The unnatural α-cysteine analogue contains a methyl group in place
of the hydrogen atom at the quaternary carbon. This increased bulk at the quaternary
center may lead to increased stability of the disulfide bond while still maintaining the
disulfide bond.

Scheme 31. Synthesis of unnatural glutathione analogues by Masterson et al.43
The synthetic methodology described above is advantageous for several reasons.
In each of the syntheses, the chiral center is generated in high enantioselectivity through
the use of PLE. This eliminates the need for an expensive chiral auxiliary. Additionally,
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the chemistry is straightforward and several analogues of cysteine are synthesized in
good yield and enantioselectivity through manipulation of protecting groups.
Furthermore, Masterson demonstrated that it is possible to incorporate the unnatural αmethyl cysteine into a glutathione analogue.43
Glutathione – Structure, Properties and Importance
Glutathione (GSH) is a tripeptide consisting of the amino acids L-γ-glutamic acid,
cysteine, and glycine (Glu-Cys-Gly). Interestingly, the glutathione contains a gamma
peptide bond between the amine group of the cysteine and the carboxyl group of the
glutamic acid. This unique peptide bond is thought to improve the stability of the
tripeptide against degradation by several peptidases.163 Glutathione is found mainly in
the reduced form but can be oxidized to form a disulfide bond, giving glutathione
disulfide (GSSG) (Scheme 32).
GSH is able to reduce disulfide bonds because of the reducing nature of the thiol
group. In the process of reducing disulfide bond, glutathione becomes oxidized to
glutathione disulfide. The enzyme glutathione reductase (GR) is able to reduce GSSG
back to GSH. Approximately 90% of the glutathione in the cell exists in the reduced
form.164 The ratio of GSH to GSSG provides an important indicator of oxidative
stress.165
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Scheme 32. Reduced glutathione (GSH) and oxidized glutathione (GSSG).
Glutathione served as the model compound to test hypothesis 3. As
demonstrated, the unnatural glutathione analogue is straightforward to synthesize.
Additionally, the stability of the unnatural glutathione analogue can be monitored through
a UV-Vis assay commercially available from Aldrich. Finally, the natural glutathione
disulfide could be purchased from Aldrich and be used as a control molecules for the
study.
Results and Discussion
Glutathione reductase assay to test the stability of an unnatural glutathione analogue
The stability of an unnatural glutathione analogue (mGSSG) against glutathione
reductase was monitored using a commercially available glutathione reductase (GR)
assay kit from Sigma Aldrich. The rate of background reaction of NADPH and either
GSSG or mGSSG in the absence of the enzyme was first measured. The absorption data
versus time produced linear graphs with very shallow slopes indicating reduction of the
disulfide bond does not readily occur with either analogue in the absence of enzyme.

119

Figure 46. Comparison of GSSG and unnatural mGSSG analogue.
Next, the activity of the glutathione reductase (GR) enzyme was measured with
GSSG and mGSSG using UV and colorimetric GR assays. The absorbance was
monitored at 340 nm for the UV assay and 412 nm for the colorimetric assay. GR
enzyme showed good reductase activity with GSSG in the presence of NADPH. The rate
of absorbance change was -1.34 x 10-3 ΔA/sec. This rate is significantly faster than the
rate without enzyme, indicating that there is good enzymatic activity with GSSG. In the
case of mGSSG, the rate of absorbance change was significantly decreased as compared
to that of GSSG. The rate was determined to be -2.21 x 10-5 ΔA/s and is very similar to
the rate of the absorbance change of the blank. This result indicated that there was no
activity of the GR enzyme with the mGSSG analogue, demonstrating that the disulfide
bond was not undergoing enzymatic reduction (Figure 47). The UV assay was performed
in collaboration with Dr. Brant Kedrowski at the University of Wisconsin Oshkosh.
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Figure 47. Glutathione reductase UV assay. Circles represent the assay using GSSG.
Squares represent the assay with mGSSG. In this case, reduction is occurring with GSSG
but not with mGSSG. (Figure originally published in Journal of Enzyme Inhibition and
Medicinal Chemistry.52).
The colorimetric assay confirmed the results of the UV assay. The rate of change
in absorbance was monitored at 412 nm. GR was able to reduce the disulfide bond of
GSSG but not mGSSG (Figure 48).
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Figure 48. Glutathione reductase colorimetric assay. Circles represent the assay using
GSSG. Squares represent the assay with mGSSG. In this case, reduction is occurring
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with GSSG but not with mGSSG. (Figure originally published in Journal of Enzyme
Inhibition and Medicinal Chemistry.52).
Next, a series of enzyme kinetic assays were performed to determine if the
mGSSG would act as an inhibitor for the glutathione reductase (GR) enzyme. The
mGSSG was evaluated for inhibitory properties due to its close structural similarity to the
natural GSSG. A series of solutions containing varying amounts of the mGSSG were
prepared. The colorimetric assay was performed again varying the concentration of
GSSG in the presence of 0 µM, 20 µM, 75 µM, and 90 µM mGSSG solutions. The
initial velocity was plotted versus GSSG concentration for each mGSSG concentration
(Figure 49).
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Figure 49. GR activity at various concentrations of mGSSG. The error bars represent the
standard deviation in 3 assays. (Figure originally published in Journal of Enzyme
Inhibition and Medicinal Chemistry.52).
The data was imported into GraphPad Prism® software. Using the built in data
analysis programs, the data was fit to inhibition models for uncompetitive, noncompetitive, and mixed mode inhibition. The data fit each of the models reasonably well
with mixed model inhibition providing the best fit (R2 = 0.9363) (Table 5).
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Table 5
Comparison of different inhibition modes for GSSG
1.
2.
3.
4.

Global Fit Value (R2)
0.8955
0.9228
0.9265
0.9363

Model
Uncompetitive
Competitive
Non-competitive
Mixed model

From GraphPad Prism® data, it is clear that the data fits each of the inhibition
models reasonable well and to a similar extent. However, it was not possible to discern
the mode of inhibition from this data alone. Therefore, the data was plotted as a
Lineweaver-Burk plot. The Lineweaver-Burk plot is consistent with competitive
inhibition (Figure 50).
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Figure 50. Lineweaver-Burk plot. Results indicate competitive inhibition. (Figure
originally published in Journal of Enzyme Inhibition and Medicinal Chemistry.52).
An ab initio computational study was performed by collaborators at the
University of Wisconsin Oshkosh to gain a better understanding of the interactions
occurring between the substrate (mGSSG or GSSG) and GR. The substrate was docked
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inside the active site of the GR enzyme, and the geometries were optimized. Based on
the computational study, the mGSSG is able to fit into the active site of the GR enzyme
even though the methyl group has added extra bulk to the mGSSG. An overlay of
mGSSG and GSSG with in the active site of GR is depicted in Figure 51. The atoms of
the active site have been removed from the figure for clarity. This figure clearly shows
the two structures overlap very closely except in the disulfide region. In the disulfide
region, the mGSSG is twisted in comparison to the GSSG.
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Figure 51. GSSG docked within the active site of GR enzyme. Standard (yellow)
coloring is used for the GSSG disulfide. The mGSSG is depicted in purple. (Figure
originally published in Journal of Enzyme Inhibition and Medicinal Chemistry.52).
The dihedral angles of both the mGSSG and GSSG in the GR active site were
determined to be 62.2˚ and 84.5˚, respectively. A Newman projection of the two
disulfide bonds looking at the C-S-S-C bond clearly show the change in dihedral angle
(Figure 52). The dihedral angle shows that there is clear twisting of the mGSSG. This
twist in conformation of the mGSSG disulfide bond possibly accounts for the lack of
reduction of mGSSG by the glutathione reductase enzyme.
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Figure 52. Newman projections for the natural GSSG (left) and the mGSSG (right). The
mGSSG has a decrease dihedral angle of 62.2 degrees compared to that of the GSSG.
Conclusions
An unnatural methyl glutathione analogue was evaluated for stability against the
glutathione reductase enzyme. The unnatural glutathione was not reduced by the
enzyme. It was found that the unnatural glutathione acts as an inhibitor of the glutathione
reductase enzyme. Computational studies were conducted to evaluate the substrate in the
active site of the enzyme. The unnatural glutathione takes on a twisted conformation in
the active site of GR enzyme. The dihedral angle of the unnatural glutathione was
calculated to be 62.2˚ as compared to the dihedral angle of the natural glutathione, 84.5˚.
This twisting of the disulfide bond may account for the GR enzymes inability to reduce
the disulfide bond of the unnatural glutathione disulfide. The glutathione peptide that has
the cysteine replaced with methyl cysteine is more stable against the glutathione
reductase enzyme.
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Experimental
Materials and methods
A Glutathione Reductase Assay kit was purchased from Sigma-Aldrich (catalog
number GRSA). The kit included assay buffer containing pH 7.5 aqueous buffer of 100
mM potassium phosphate with 1 mM EDTA; dilution buffer containing the same
contents as the assay buffer with 1 mg/mL bovine serum albumin; and enzyme solution
prepared by dissolving one vial of enzyme in 1 mL of water to prepare a solution of GR
with an activity of > 1 unit/mL. Fresh solutions of GSSG, mGSSG, NADPH, and DTNB
were prepared with assay buffer according to kit instructions immediately before the
assay. Disposable plastic cuvettes (1.5 mL) were purchased from Plastibrand.
Glutathione Reductase blank runs Colorimetric Assay
A solution of NADPH was mixed with glutathione in the presence of DTNB. The
increase in absorbance was measured at 412 nm over the course of 170 seconds following
an initial lag period of 60 seconds. The solution contained 500 µL 2 mM GSSG or
mGSSG; 200 µL assay buffer; 250 µL 3 mM DTNB; and 50 µL 2 mM NADPH solution
for a total solution volume of 1.0 mL. The change in absorbance was recorded at 412 nm
every 10 s for a total of 170 seconds, after an initial lag period of 60 seconds. The
procedure was repeated in triplicate and plotted as the average change in absorbance
versus time. The error bars indicate standard deviation between the three analyses.
Glutathione Reductase Colorimetric Assay with enzyme
A solution of NADPH was mixed with glutathione in the presence of DTNB. The
increase in absorbance was measured at 412 nm over the course of 170 seconds following
an initial lag period of 60 seconds. The solution contained 500 µL 2 mM GSSG or
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mGSSG, 190 µL assay buffer, 250 µL 3 mM DTNB, 10 µL enzyme solution, and 50 µL
2 mM NADPH solution for a total solution volume of 1.0 mL. The change in absorbance
was recorded at 412 nm every 10 s for a total of 170 seconds, after an initial lag period of
60 seconds. The procedure was repeated in triplicate and plotted as the average change in
absorbance versus time. The error bars indicate standard deviation between the three
analyses.
Glutathione Reductase Inhibition Assays
A 2 mM stock solution of the GSSG was prepared by dissolving 1.225 mg of
GSSG per 1.0 mL assay buffer. This GSSG stock solution was used to prepare a series of
working solutions ranging in concentration from 0.02 mM to 0.08 mM GSSG. A 2 mM
stock solution of the mGSSG was prepared by dissolving 1.42 mg mGSSG per 1.0 mL
assay buffer. The mGSSG stock solution was used to prepare working solutions with
concentrations of 0.02 mM, 0.075 mM, and 0.09 mM. For the assay, the solutions were
mixed in the following order: 250 µL GSSG, 250 µL mGSSG, 190 µL assay buffer, 10
µL enzyme solution, 250 µL DTNB, and 50 µL NADPH. The solutions were mixed by
inversion and placed in the spectrometer. After an initial 60 second delay, the absorbance
at 412 nm was recorded every 10 s for a total of 170 seconds. The assay was repeated in
triplicate at each substrate/inhibitor concentration. The absorbance at each time point
was averaged and plotted. The error bars represent the standard deviation in the three
assays.
Computational Methods
Computational studies were performed at the University of Wisconsin at
Oshkosh. Published crystallographic data for GSSG bound to human GR was used as a
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starting point.166 GSSG and mGSSG were docked within the active site of the GR
enzyme. The atoms of the enzyme and water that were within 6.0 angstroms of the
GSSG were included to simplify calculations. This does include some atoms from the
neighboring protein in the unit cell. Hydrogen atoms were excluded by X-ray data, but
later added using the add hydrogen feature of Jmol (www.jmol.org). The positions of
the hydrogen atoms were optimized using the MMF94F force field within the Avogadro
software (http://avogadro.openmolecules.net). The ab initio geometry optimization of
the ligand was performed using the GAMESS software package running on a computer
cluster with 32 processors and 64 GB of RAM. The positions of the protein atoms and
water were fixed during this step. This approach has been described in previous work by
Kokubo and Riley.167,168 The geometry of the natural GSSG substrate was optimized
using the restricted Hartree-Fock method and a 3-21G basis set. Optimization at this step
was in good agreement with the experimental crystallographic data. The unnatural
substrate mGSSG was substituted into the active site for the GSSG in the calculations,
and the same geometry optimizations were performed.
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CHAPTER V
FUTURE DIRECTIONS
As with all research, each question answered leads to another question asked.
This chapter will focus on the progress from Chapters II through IV with possible future
expansions for these projects.
What are other factors that influence the enantioselectivity of PLE?
As discussed in Chapter II, there is a correlation between the addition of ethanol
and an increase in enantioselectivity for the PLE hydrolysis reaction. However, this
relationship seems to only exist for certain substrates, for example 1, 2, and 10. For
example, although analogues 12a-c contain a nitrogen atom in the ring, the outcome of
the hydrolysis reaction was not influenced to the same magnitude. These results indicate
that there is another factor to consider in addition to the hydrogen bonding nature of the
side chain. One possibility is that the size of the side chain plays a role in the
enantioselective outcome of the reaction.
In order to further investigate if there is a correlation between the size of the
molecule and the influence of cosolvent, molecular modeling studies can be conducted on
the molecules. The area and volume of the side chain can be calculated using Spartan or
similar molecular modeling software. The volume of the substrate can be compared to
the volume of the pockets of the Jones Active Site model for the PLE active site.70 By
considering the size of the molecule compared to the size of the active site pockets, we
may be able to predict which molecules will provide better enantioselectivity upon
hydrolysis with PLE.
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To gain a better understanding of the interactions that occur between the substrate
and enzyme, substrates can be prepared that have different characteristics. There are
endless possibilities when deciding the substrates that should be synthesized. One factor
that may influence the enantioselectivity of the PLE hydrolysis reaction is aromaticity. A
series of substrates analogous to those discussed in this dissertation can be prepared by
similar synthetic methods as previously described. The analogues would maintain
structural similarity to those described in this dissertation, however, the aromatic
character of the molecule would be altered. Once the diester substrates are synthesized,
PLE hydrolysis can be performed. The enantioselectivity can be measured and compared
to the substrates analogue to gauge how the aromaticity of the reaction affects the
enantioselectivity of the PLE hydrolysis reaction. Several possible analogues are shown
in Figure 53.

Figure 53. Possible analogues to probe the influence of aromaticity in the PLE hydrolysis
reaction.
Improving the enantioselectivity of nonpolar substrates
One area that has been particularly troubling is the hydrolysis of more nonpolar
substrates, such as substrate 5. These substrates typically provide poor enantioselectivity
upon hydrolysis with crude PLE.20,36,44 Half-ester 6 has been produced in >97% ee by
using the enzyme α-chymotrypsin; however, the reaction is extremely slow and provides
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very poor yield. The mass spectrometry assay could be used to determine
cosolvent/enzyme conditions that provide high yield and enantioselectivity.
Improvements to mass spectrometry assay
Chapter III discussed the use of molecules that are structurally similar to the
products of PLE hydrolysis reactions as standards to determine both yield and
enantioselectivity in a single analysis. Several factors can be optimized to make this
assay more high-throughput. First, alternative chromatography conditions can be worked
out so that each analysis takes place as quickly as possible. Additionally, the autosampler
can be used to add and mix the standard into each sample. This would decrease the
amount of time taken for sample preparation by the user. Addition of the standard by the
autosampler would also ensure that variation in the amount of standard added to each
sample was minimal. The yield and enantioselectivity assay can be further extended to
include APCI mass spectrometry. Typical analysis times for the APCI MS method were
an hour long. The yield assay can be adapted for use with APCI MS as well in order to
gain the most data from one analysis.
The mass spectrometry assay can also be applied in the screening of hydrolysis
conditions for new substrates that will be synthesized. In addition, a variety of conditions
for the hydrolysis of nonpolar substrates can be studied using this assay. By screening a
large number of cosolvent/enzyme conditions, combinations that provide levels of high
enantioselectivity and yield will be determined quickly.
Glutathione Reductase Inhibitors
As discussed in Chapter III, the oxidized methylated glutathione was determined
to be a competitive inhibitor of glutathione reductase.52 In addition to the G’SSG’
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analogue that has already been synthesized and evaluated, a variety of other analogues
can be synthesized. One possibility is to synthesize a mixed glutathione disulfide (Figure
54). In the mixed glutathione disulfide, one cysteine would remain the natural cysteine
while α-methyl cysteine could be incorporated into the other half of the molecule. A
mixed glutathione disulfide molecule should have properties that lie somewhere between
those of natural GSSG and G’SSG’.

Figure 54. Structure of GSSG’ mixed disulfide.
Kedrowski has shown that it is possible to synthesize both enantiomers of αmethyl cysteine.42 Masterson has reported the synthesis of several unnatural cysteine
amino acid molecules, including both enantiomers of the β2,2 and β3,3 analogues of
cysteine.12 One can envision creating a library of various glutathione molecules that
incorporate the various analogues of cysteine through straightforward chemistry.43 The
glutathione analogues can then be tested for their inhibitory properties against the
glutathione reductase enzyme using the commercially available glutathione reductase
assay kit.
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Figure 55. Cysteine analogues to be incorporated into GSSG.
The cysteine analogues would be prepared according to previously reported
literature procedures.12,42 Once the unnatural cysteine analogue is synthesized, an
unnatural glutathione analogue can be synthesized using chemistry that has been
previously reported.43 A synthetic strategy for a glutathione analogue containing the β2,2cysteine is illustrated below (Scheme 33).

Scheme 33. Synthesis of an unnatural glutathione analogue containing a β2,2 cysteine
analogue. Conditions and reagents: (a) LiOH; (b) DIPEA, PyBroP, CH2Cl2; (c) 10%
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TFA, CH2Cl2, thioanisole; (d) Boc-L-glutamic acid 1-tertbutyl ester, DIPEA, PyBroP,
CH2Cl2; (e) (i) LiOH, THF, H2O; (ii) 50% TFA, CH2Cl2; (f) (i) Hg(OAc)2, TFA; (ii)
H2S/H2O; and (g) NH4OH, H2O (pH 8.0), O2.
Glutathione has been of particular interest due to its potential as an anti-malarial
agent.169 The malarial parasite is thought to be more sensitive towards oxidative stress.
Several groups have developed inhibitors of glutathione reductase for the treatment of
malaria.170,171 By inhibiting glutathione reductase, the parasite cannot survive. Our
methylated glutathione and other analogues can be studied for their use as antimalarial
agents.

135
APPENDIX

A. 1 a) 1H-NMR of 7; b) 13C-NMR of 7.
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A. 2 a) 1H-NMR of 7; b) 13C-NMR of 7.
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A. 3 a) 1H-NMR of 12a; b) 13C-NMR of 12a.
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A. 4. a) 1H-NMR of 12b; b) 13C-NMR of 12b.
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A. 5. a) 1H-NMR of 12c; b) 13C-NMR of 12c.
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A. 6. a) 1H-NMR of 15; b) 13C-NMR of 15.
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A. 7. a) 1H-NMR of 16; b) 13C-NMR of 16.
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A. 8. a) 1H-NMR of 17a; b) 13C-NMR of 17a.
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A. 9. a) 1H-NMR of 17b; b) 13C-NMR of 17b.

144

A. 10. a) 1H-NMR of 17c; b) 13C-NMR of 17c.
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A. 11. a) 1H-NMR of 18a; b) 13C-NMR of 18a.
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A. 12. a) 1H-NMR of 18b; b) 13C-NMR of 18b.
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A. 13. a) 1H-NMR of 18c; b) 13C-NMR of 18c.
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A. 14. a) 1H-NMR of 21; b) 13C-NMR of 21.
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A. 15. A) 1H-NMR of 22; b) 13C-NMR of 22.
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A. 16. a) 1H-NMR of probe-23; b) 13C-NMR of probe-23.
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A. 17. A) 1H-NMR of probe-24; b) 13C-NMR of probe-24.
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A. 18. 13C-NMR stackplot of NMR titration of substrate 3 with EtOH.
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A. 19. 13C-NMR stackplot of NMR titration of substrate 5 with EtOH.
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A. 20. 13C-NMR stackplot of NMR titration of substrate 1 with i-PrOH.
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A. 21. 13C-NMR stackplot of NMR titration of substrate 3 with i-PrOH.
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A. 22. 13C-NMR stackplot of NMR titration of substrate 5 with i-PrOH.
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A. 23. 13C-NMR stackplot of NMR titration of substrate 7 with EtOH.
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A. 24. 13C-NMR stackplot of NMR titration of substrate 10 with EtOH.
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A. 25. 13C-NMR stackplot of NMR titration of substrate 12a with EtOH.
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A. 26. 13C-NMR stackplot of NMR titration of substrate 12b with EtOH.
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A. 27. 13C-NMR stackplot of NMR titration of substrate 12c with EtOH.
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